BERGEN, A.W.; KORCZAK, J.F.; WEISSBECKER,K.A.; ANDGOLDSTEIN, A.M.A genome-wide search for loci contributing to smoking and alcoholism. Genetic Epidemiology17(Suppl. 1):S55?60, 1999	10597412
BIERUT, L.J.; DINWIDDIE, S.H.; BEGLEITER, H.; ETAL.Familial transmission of substance dependence:Alcohol, marijuana, cocaine, and habitual smoking:A report from the Collaborative Study on the Geneticsof Alcoholism [see comments]. Archives of GeneralPsychiatry55:982?988, 1998.	9819066
BIERUT, L.J.; RICE, J.P.; EDENBERG, H.J.; ETAL.Family-based study of the association of the dopamineD2 receptor gene (DRD2) with habitual smoking.AmericanJournal of Medical Genetics90:299?302,2000.	10710227
BRESLAU, N.Psychiatric comorbidity of smokingand nicotine dependence. Behavior Genetics25:95?101, 1995.	7733862
BUCHOLZ, K.K.; CADORET, R.; CLONINGER, C.R.;ETAL.A new, semi-structured psychiatric interviewfor use in genetic linkage studies: A report on thereliability of the SSAGA. Journal of Studies on Alcohol55:149?158, 1994.	8189735
CHATTERJI, S.; SAUNDERS, J.B.; VRASTI, R.; ETAL.Reliability of the alcohol and drug modules of theAlcohol Use Disorder and Associated DisabilitiesInterview Schedule?Alcohol/Drug-Revised(AUDADIS?ADR): An international comparison.Drug & Alcohol Dependence47:171?185, 1997.	9306043
EDENBERGH, H.J.; FOROUD, T.; KOLLER, D.L.; ETAL.A family-based analysis of the association of thedopamine D2 receptor (DRD2) with alcoholism.Alcoholism: Clinical and Experimental Research 22(2):505?512, 1998.	9581660
FEIGHNER, J.P.; ROBINS, E.; GUZE, S.B.; ETAL.Diagnostic criteria for use in psychiatric research.Archives of General Psychiatry26:57?63, 1972.	5009428
FOROUD, T.; EDENBERG, H.J.; GOATE, A.; ETAL.Alcoholism susceptibility loci: Confirmation studiesin a replicate sample and further mapping. Alcoholism:Clinicaland Experimental Research24(7):933?945, 2000.	10923994
GLASSMAN, A.H.; HELZER, J.E.; COVEY, L.S.; ETAL.Smoking, smoking cessation, and major depres-sion. Journal of the American Medical Association264:1546?1549, 1990.	2395194
GRANT, B.F., ANDHARFORD, T.C. Comorbiditybetween DSM?IV alcohol use disorders and majordepression: Results of a national survey. Drug &Alcohol Dependence 39:197?206, 1995.	8556968
HEATH, A.C.; BUCHOLZ, K.K.; MADDEN, P.A.; ETAL.Genetic and environmental contributions toalcohol dependence risk in a national twin sample:Consistency of findings in women and men.Psychological Medicine27:1381?1396, 1997.	9403910
REICHT.; EDENBERG, H.J.; GOATE, A.; ETAL.Genome-wide search for genes affecting the risk foralcohol dependence. American Journal of MedicalGenetics(Neuropsychiatric Genetics) 81:207?215,1998.	9603606
SMITH, S.S.; O?HARA, B.F.; PERSICO, A.M.; ETAL.Genetic vulnerability to drug abuse: The D2 dopaminereceptor Taq I B1 restriction fragment length poly-morphism appears more frequently in polysubstanceabusers. Archives of General Psychiatry49:723?727,1992.	1355337
SPITZ, M.R.; SHI, H.; YANG, F.; ETAL.Case-con-trol study of the D2 dopamine receptor gene andsmoking status in lung cancer patients. Journal ofthe NationalCancer Institute90:358?363, 1998.	9498485
TRUE, W.R.; HEATH, A.C.; SHERRER, J.F.; ETAL.Genetic and environmental contributions to smok-ing. Addiction92:1277?1287, 1997.	9489045
TRUE, W.R.; XIAN, H.; SCHERRER, J.F.; ETAL.Common genetic vulnerability for nicotine andalcohol dependence in men. Archives of GeneralPsychiatry56:655?661, 1999.	10401514
KESSLER, R.C.; MCGONAGLE, K.A.; ZHAO, S.; ETAL. Lifetimeand 12-month prevalence of DSM?III?R psychiatric disorders inthe United States. Results from the National ComorbiditySurvey. Archives in General Psychiatry51(1):8?19, 1994.	8279933
WARNER, L.A.; KESSLER, R.C.; HUGHES, M.; ANTHONY, J.C.;ANDNELSON, C.B. Prevalence and correlates of drug use anddependence in the United States. Results from the NationalComorbidity Survey. Archives in General Psychiatry52(3):219?229, 1995.	7872850
3. Benita S, Benoit JP, Puisieux F, Thies C.Characterization of drug-loaded poly(d,l-lactide) microspheres. J Pharm Sci.1984;73:1721-1724.	6527243
4. Mathews BR, Nixon JR. Surface characteristicsof gelatin microcapsules by scanning electronmicroscopy. J Pharm Pharmacol.1974;26:383-384.	4153096
5. Bodmeier R, McGinity J. Polylactic acidmicrospheres containing quinidine base andquinidine sulphate prepared by the solventevaporation technique. I. Methods andmorphology. J Microencapsul. 1987;4:279-288.	3504509
7. De Smedt SC, Meyvis TKL, Van Oostveldt P,Demeester J. A new microphotolysis basedapproach for mapping the mobility of drugs inmicroscopic drug delivery devices. Pharm Res.1999;16:1639-1642.	10554110
8. Bouillot P, Babak V, Dellacherie E. Novelbioresorbable and bioeliminable surfactants formicrosphere preparation. Pharm Res.1999;16:148-154.	9950294
9. Adler J, Jayan A, Melia CD. A method forquantifying differential expansion withinhydrating hydrophilic matrixes by trackingembedded fluorescent microspheres. J PharmSci. 1999;88:371-377.	10052997
10. Rojas J, Pinto-Alphandary H, Leo E, PecquetS, Couvreur P, Gulik A, Fattal E. Apolysorbate-based non-ionic surfactant canmodulate loading and release of beta-lactoglobulin entrapped in multiphasepoly(DL-lactide-co-glycolide) microspheres.Pharm Res. 1999;16:255-260.	10100311
11. Caponetti G, Hrkach JS, Kriwet B, Poh M,Lotan N, Colombo P, Langer R. Microparticlesof novel branched copolymers of lactic acidand amino acids: preparation andcharacterization. J Pharm. Sci 1999;88:136-141.	9874715
12. Lamprecht A, Schï¿½fer UF, Lehr, CM.Characterisation of microcapsules by confocallaser scanning microscopy: analysis ofstructure, capsule wall composition and ofencapsulation rate. Eur J Pharm Biopharm.2000;49:1-9.	10613921
13. Alex R, Bodmeier R. Encapsulation of water-soluble drugs by a modified solventevaporation method. I. Effect of process andformulation variables on drug entrapment. JMicroencapsul. 1989;7:347-355.	2384837
14. Iwata M, McGinity JW. Preparation of multi-phase microspheres of poly(lactic acid) andpoly(lactic-co-glycolic acid) containing a W/Oemulsion by a multiple solvent evaporationtechnique. J Microencapsul. 1992;9:201-214.	1593404
15. Schreiber AB, Haimovich J. Quantitativefluorometric assay for detection andcharacterization of Fc receptors. Meth Enzymol.1983;93:147-155.	6865782
16. Luzzi LA, Gerraughty RJ. Effects of selectedvariables on the extractability of oils fromcoacervate capsules. J Pharm Sci.1964;53:429-431.	14189940
17. Mussellwhite PR. The surface properties of anoil-water emulsion stabilized by mixtures ofcasein and gelatin. J Colloid and InterfaceScience. 1966;21:99-102.	5906905
19. Nihant N, Schugens C, Grandfils C, Jerome R,Teyssie P. Polylactide microparticles preparedby double emulsion/evaporation technique. I.Effect of primary emulsion stability. PharmRes. 1994;11:1479-1484.	7855056
20. Sezer AD, Akbuga J. Release characteristics of chitosan treated alginate beads: I. Sustained release of a macromolecular drug from chitosan treated alginate beads. JMicroencapsul. 1999;16:195-203.	10080113
21. Hari PR, Chandy T, Sharma CP.Chitosan/calcium alginate microcapsules forintestinal delivery of nitrofurantoin. JMicroencapsul. 1996;13:319-329.	8860687
22. Murata Y, Toniwa S, Miyamoto E, KawashimaS. Preparation of alginate gel beads containingchitosan nicotinic acid salt and the functions.Eur J Pharm Biopharm. 1999;48:49-52.	10477328
1. Yamashita F, Bando H, Koyama Y, Kitagawa S,Takakura, Y, Hashida, M. In vivo and in vitro analysis ofskin penetration enhancement based on a two-layer modelwith polar and non-polar routes in the stratum corneum.Pharm Res. 1994;11:185-191.	8165175
2. Phillips CA, Michiniak BB. Transdermal delivery ofdrugs with differing lipophilicities using azone analogs asdermal penetration enhances. J Pharm Sci. 1995;84:1427-1437.	8748324
3. Flynn GL, Yalkowsky SH, Roseman TJ. Masstransport phenomena and models: theoretical concepts. JPharm Sci. 1974;63:479-510.	4828694
4. Ozawa T, Takahashi M. Skin hydration: Recent Advances. Acta Derm Venereol. Suppl. 1994;185:26-28.	8091923
5. Iazzo PA, Olsen RA, Seewald MJ, Powis G, Stier A,Van Dyke RA. Transient increases of intracellular Ca++induced by volatile anesthetics in rat hepatocytes. CellCalcium. 1990;11:515-524.	2265428
6. Reed PW, Lardy HA. A23187: A divalent Cation ionophore. J Biol Chem. 1972;247:6970.	4263618
7. Wallace BA. Gramicidin channels and pores. Ann RevBiophysic Chem. 1990; 19:127	1694667
8. Araki M, Inaba H, Kon S, Imai M, Mizuguchi T.Effects of volatile anesthetics on the calcium ionophoreA23187-mediated alterations in hepatic flow andmetabolism in the perfused liver in fasted rats. ActaAnesthesiol Scan. 1997;41:55-61.	9061115
9. Plakas SM, James MO. Bioavailability, metabolism,and renal excretion of benzoic acid in the channel catfish(Ictalurus punctatus). Drug Metab Dispos.1990;18(5):552-556.	1981701
10. French DL, Haglund BO, Himmelstein KJ, MaugerJW: Controlled release of substituted benzoic andnaphthoic acids using Carbopol gels: measurement ofdrug concentration profiles and correlation to release ratekinetics. Pharm Res. 1995;12(10):1513-1520.	8584491
11. Miller GR, Smith CA, Stauber WT. Determination offibrosis from cryostat sections using high performanceliquid chromatography: skeletal muscle. Histochem J.1999;31:89-94.	10416680
12. Bartlett GR. Phosphorous assay in column chromatography. J Biol Chem. 1959;234:466-468.	13641241
14. Lee CH, Vyavahare N, Zand R, Kruth H, SchoenFJ,Bianco R,. Levy RJ. Inhibition of aortic wallcalcification in bioprosthetic heart valves by ethanolpretreatment: Biochemical and biophysical mechanisms. JBiomed Mater Res. 1998;42(1):30-37.	9740004
15. Hu W, Cross TA. Tryptophan hydrogen bonding andelectric dipole moments: functional roles in the gramicidinchannel and implications for membrane proteins.Biochemistry. 1995;34:14,147-14,155.	7578012
16. Heitz F, Gavach C. Ca+2 gramicidin A interactionsand blocking effects on the ionic channel. BiophysicalChemistry. 1983; 18:153-163.	6194829
17. Mitchell DC, Litman BJ. Effect of hydration onreceptor conformation: decreased levels of bound waterpromote metarhodopsin II formation.Biochemistry. 1999;38: 7617-7623.	10387000
19. Hwang J, Tamm LK, Bohm C, Ramalingam TS,Betzig E, Edidin M. Nanoscale complexity ofphospholipid monolayers investigated by near-fieldscanning optical microscopy. Science. 1995; 270:610-614.	7570018
20. Carruthers A, Melchior DL. Human erythrocytehexose transporter activity is governed by bilayerlipid composition in reconstituted vesicles.Biochemistry. 1984;23(26):6901-6911.	6543323
1.Bredt, D.S and Snyder, S.H. Nitric oxide, a novel neuronal messenger. Neuron 1992, 8, 3-11.	1370373
2.Cooper, J. and Walker, R.D. Listeriosis. Vet. Clin. North.Am. Food Anim. Pract. 1998, 14, 113-125.	9532671
3.Charlton, K.M. and Garcia, M.M. Spontaneous listericencephalitis and neuritis in sheep. Light microscopic studies.Vet. Pathol. 1997, 14, 297-313.	560741
4.Dramsi, S., Levi, S., Triller, A. and Cossart, P. Entry ofListeria monocytogenes into neurons occurrs by cell-to-cellspread: an in vitro study. Infect. Immun. 1998, 66, 4461-4468.	9712801
5.Greenberg, S.S., Ouyang, J., Zhao, X. and Giles, T.D.Human and rat neutrophils constitutively express neuronalnitric oxide synthase mRNA. Nitric Oxide 1998, 2, 203-212.	9731638
6.Hooper, D.C., Ohnishi, S.T., Kean, R., Numagami, Y.,Dietzschold, B. and Koprowski, H.Local nitric oxideproduction in viral and autoimmune disease of the centralnervous system. Proc. Natl. Acad. Sci. U.S.A. 1995, 92,5312-5316.	7539914
7.Johnson, G.C., Fales, W.H., Maddox, C.W. and Ramos-Vara, J.A. Evaluation of laboratory test for confirming thediagnosis of encephalitic listeriosis in ruminants. J. Vet.Diagn. Invest. 1995, 7, 223-228.	7542480
8.Jungi, T.W., Pfister, H., Sager, H., Fatzer, R., Vandevelde,M. and Zurbriggen, A.Comparison of inducible nitricoxide synthase expression in the brain of Listeriamonocytogenes-infected cattle, sheep and goats and inmacrophages stimulated in vitro. Infect. Immun. 1997, 65,5279-5288.	9393827
9.Krueger, N., Low, C. and Donachie, W. Phenotypiccharacterization of the cells of the inflammatory response inovine encephalitic listeriosis. J. Comp. Pathol. 1995, 113,263-275.	8592052
10.Kim, S., Moon, C., Wie, M., Kim, H., Tanuma, N.,Matsumoto, Y. and Shin, T.Enhanced expression ofconstitutive and inducible forms of nitric oxide synthase inautoimmune encephalomyelitis. J. Vet. Sci., 2000, 1, 11-17.	14612615
11.Moncada, S., Palmer, R.M.J. and Higgs, E.A. Nitricoxide: physiology, pathophysiology, and pharmacology.Pharmacol. Rev., 1991, 43, 109-134.	1852778
12.Murphy, S., Simmons, M.L., Agullo, L., Carcia, A.,Feinstein, D.L., Galea, E., Reis, D.J., Minc-Golomb, D.and Schwartz, J.P.Synthesis of nitric oxide in CNS glialcells. T.I.N.S. 1993, 16, 323-328.	7691008
13.Nathan, C. and Xie, Q.-W. Nitric oxide synthases: Roles,tolls and controls. Cell 1994, 78, 915-918.	7522969
14.Otter, A. and Blackmore, W.F. Observation on thepresence of Listeria monocytogenes in axons. ActaMicrobiol. Hung. 1989, 36, 125-131.	2517159
15.Reiling, N., Ulmer, A.J., Duchrow, M., Ernst, M., Flad,H.D. and Hauschildt, S.Nitric oxide synthase: mRNAexpression of different isoforms in human monocytes/macrophages. Eur. J. Immunol. 1994, 24, 1941-1944.	7520003
16.Reiling, N., Kroncke, R., Ulmer, A.J., Gerdes, J., Flad,H.D. and Hauschildt, S.Nitric oxide synthase: expressionof the endothelial, Ca2+/calmodulin-dependent isoform inhuman B and T lymphocytes. Eur. J. Immunol. 1996, 26,511-516.	8605914
17.Rouquette, C. and Berche, P. The pathogenesis of infectionby Listeria monocytogenes. Microbiologia 1996, 12, 245-258.	8767708
18.Sinz, E.H., Kochanek, P.M., Dixon, C.E., Clark, R.S.,Carcillo, J.A., Schiding, J.K., Chen, M., Wisniewski,S.R., Carlos, T.M., William, D., DeKosky, S.T., Watkins,S.C., Marion, D.W. and Billiar, T.R.Inducible nitric oxidesynthase is an endogenous neuroprotectant after traumaticbrain injury in rats and mice. J. Clin. Invest. 1999, 104, 647-656.	10487779
19.Wu, J., Lin, Q., Lu, Y., Willis, W.D. and Westlund, K.N.Changes in nitric oxide synthase isoforms in the spinal cordof rat following induction of chronic arthritis. Exp. BrainRes. 1998, 118, 457-465	9504841
1.Kalender WA, Sissler W, Klotz E, Vock P. Spiralvolumetric CT with single-breath-hold technique,continuous transport, and continuous scanner ro-tation. Radiology1990;176:181?183	2353088
2.Crawford CR, King K. Computed tomographyscanning with simultaneous patient translation.Med Phys 1990;17:967?982	2280740
3.Remy-Jardin M, Remy J, Giraud F, MarquetteCH. Pulmonary nodules: detection with thick-section spiral CT versus conventional CT. Radiol-ogy1993;187:513?520	8475300
4.Buckley JA, Scott WW, Siegelman SS, et al. Pul-monary nodules: effect of increased data sam-pling on detection with spiral CT and confidencein diagnosis. Radiology1995;196:395?400	7617851
5.Costello P. Thoracic helical CT. RadioGraphics1994;14:913?918	7938778
6.Costello P, Dupuy DE, Ecker CP, Tello R. Spiral CTof the thorax with reduced volume of contrastmaterial: a comparative study. Radiology1992;183:663?666	1584915
7.Cascade PN, Gross BH, Kazerooni EA, et al.Variability in the detection of enlarged mediasti-nal lymph nodes in staging lung cancer: a com-parison of contrast-enhanced and unenhanced CT.AJR1998;170:927?931	9530036
8.Hopper KD. With helical CT, is nonionic contrasta better choice than ionic contrast for rapid andlarge IV bolus injections (answer to question)?AJR1996;166:715	8623657
9.Debatin J, Cohan RH, Leder RA, Zakrzewski CB,Dunnick NR. Selective use of low-osmolar con-trast media. Invest Radiol 1991;26:17?21	2022448
10.Cohan RH, Dunnick NR, Leder RA, et al. Extrava-sation of nonionic contrast media: efficacy of con-servative treatment. Radiology1990;176:65?67	2353113
11.Hopper KD, Mosher TJ, Kasales CJ, TenHave TR,Tully DA, Weaver JS. Thoracic spiral CT: deliveryof contrast material pushed with injectable saline so-lution in a power injector. Radiology1997;205:269?271	9314997
12.Rubin GD, Lane MJ, Bloch DA, Leung AN, StarkP. Optimization of thoracic spiral CT: effects ofiodinated contrast medium concentration. Radiol-ogy1996;201:785?791	8939232
2.Oliver TW Jr, Bernardino ME, Miller JI, MansourK, Greene D, Davis WA. Isolated adrenal massesin nonsmall-cell bronchogenic carcinoma. Radiol-ogy1984;153:217?218	6473783
3.Welch TJ, Sheedy PF II, Stephens DH, JohnsonCM, Swenson SJ. Percutaneous adrenal biopsy: re-view of 10-year experience. Radiology1994;193:341?344	7972740
4.Mody MK, Kazerooni EA, Korobkin M. Percuta-neous CT-guided biopsy of adrenal masses: imme-diate and delayed complications. J Comput AssistTomogr 1995;19:434?439	7790554
5.Lee MJ, Hahn PF, Papanicolaou N, et al. Benignand malignant adrenal masses: CT distinction withattenuation coefficients, size, and observer analy-sis. Radiology1991;179:415?418	2014283
6.van Erkel AR, van Gils APG, Lequin M, Kruit-wagen C, Bloem JL, Falke THM. CT and MR dis-tinction of adenomas and nonadenomas of theadrenal glands. J Comput Assist Tomogr1994432?438	8188912
8.Korobkin M, Brodeur FJ, Yutzy GG, et al. Differen-tiation of adrenal adenomas from nonadenomas us-ing CT attenuation values. AJR1996;166:531?536	8623622
9.Mitchell DG, Crovello M, Matteucci T, PetersenRO, Miettinen MM. Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology1992;185:345?351	1410337
10.Tsushima Y, Ishizaka H, Matsumoto M. Adrenalmasses: differentiation with chemical shift, fastlow-angle shot MR imaging. Radiology1993;186:705?709	8430178
11.Mayo-Smith WW, Lee MJ, McNicholas MM,Hahn PF, Boland GW, Saini S. Characterization ofadrenal masses (<5 cm) by use of chemical shiftMR imaging: observer performance versus quanti-tative measures. AJR1995;165:91?95	7785642
12.Korobkin M, Lombardi TJ, Aisen AM, et al. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology1995;197:411?418	7480685
13.McNicholas MMJ, Lee MJ, Mayo-Smith WW,Hahn PF, Boland GW, Mueller PR. An imaging al-gorithm for the differential diagnosis of adrenal ad-enomas and metastases. AJR1995;165:1453?1459	7484585
14.Schwartz LH, Panicek DM, Doyle MV, et al. Com-parison of two algorithms and their associatedcharges when evaluating adrenal masses in patientswith malignancies. AJR1997;168:1575?1578	9168729
15.Dwamena BA, Kloos RT, Fendrick AM, et al. Di-agnostic evaluation of the adrenal incidentaloma:decision and cost-effectiveness analyses. Nucl Med1998;39:707?712	9544685
16.Smith TJ, Hillner BE, Neighbors DM, McSorleyPA, Le Chevalier T. Economic evaluation of a randomized clinical trial comparing vinorelbine, vinorelbine plus cisplatin, and vindesine plus cisplatin for non-small-cell lung cancer. J Clin On-col1995;13:2166?2173	7666075
17.Sandler MA, Pearlberg JL, Madrazo BL, GitschlagKF, Gross SC. Computed tomographic evaluationof the adrenal gland in the preoperative assessmentof bronchogenic carcinoma. Radiology1982;145:733?736	7146405
18.Pagani JJ. Non-small cell lung carcinoma adrenalmetastases: computed tomography and percutane-ous needle biopsy in their diagnosis. Cancer198453:1058?60	6692299
19.Salvatierra A, Baamonde C, Llamas JM, Cruz F,Lopez-Pujol J. Extrathoracic staging of bron-chogenic carcinoma. Chest1990;97:1052?1058	2184992
20.Silverman SG, Mueller PR, Pinkney LP, KoenkerRM, Seltzer SE. Predictive value of image-guidedadrenal biopsy: analysis of results of 101 biopsies.Radiology1993;187:715?718	8497619
21.Malenka DJ, Colice GL, Jacobs C, Beck JR. Medi-astinal staging in non-small-cell lung cancer. MedDecis Making1989;9:231?242	2552250
22.Damhuis RA, Schutte PR. Resection rates andpostoperative mortality in 7,899 patients with lungcancer. Euro Respir J 1996;9:7?10	8834326
23.Vrdoljak E, Mise K, Sapunar D, Rozga A, MarusicM. Survival analysis of untreated patients with non-small-cell lung cancer. Chest1994;106:1797?1800	7988203
24.Bunn PA Jr. The treatment of non-small cell lung can-cer: current perspectives and controversies, future di-rections. Semin Oncol1994;21[suppl 6]:49?59	8052874
26.Eisenberg JM. Clinical economics: a guide to theeconomic analysis of clinical practices. JAMA1989;262:2879?2886	2509745
28.Outwater EK, Siegelman ES, Huang AB, Birn-baum BA. Adrenal masses: correlation betweenCT attenuation value and chemical shift ratio atMR imaging with in-phase and opposed-phase se-quences. Radiology1996;200:749?752	8756926
29.Korobkin M, Giordano TJ, Brodeur FJ, et al. Adre-nal adenomas: relationship between histologiclipid and CT and MR findings. Radiology1996200:743?747	8756925
30.Ries LA. Influence of extent of disease, histology,and demographic factors on lung cancer survival inthe SEER population-based data. Semin Surg On-col1994;10:21?30	8115783
31.Jaakkimainen L, Goodwin PJ, Pater J, Warde P,Murray N, Rapp E. Counting the costs of chemo-therapy in a National Cancer Institute of Canadarandomized trial in nonsmall-cell lung cancer. Clin Oncol1990;8:1301?1309	2166142
32.Korobkin M, Brodeur FJ, Francis IR, Quint LE,Dunnick NR, Goodsitt M. Delayed enhanced CTfor differentiation of benign from malignant adre-nal masses. Radiology1996;200:737?742	8756924
33.Boland GW, Hahn PF, Pena C, Mueller PR. Adre-nal masses: characterization with delayed contrast-enhanced CT. Radiology1997;202:693?696	9051018
34.Boland GW, Goldberg MA, Lee MJ, et al. Indeter-minate adrenal mass in patients with cancer:evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology1995;194:131?134	7997539
35.Erasmus JJ, Patz EF Jr, McAdams HP, et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positronemission tomography. AJR1997;168:1357?1360	9129444
36.Tengs TO, Adams ME, Pliskin JS, et al. Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal1995;15:369?390Adrenal Mass EvaluationAJR:174, April 20001039	7604170
1.Puri P, Blake N, O?Donnell B, Guiney EJ. De-layed primary anastomosis following spontane-ous growth of esophageal segments in esophagealatresia.J Pediatr Surg1981;16:180?183	7241321
2.Tam PKH, Chan FL, Saing H. Diagnosis andevaluation of esophageal atresia by direct sagittalPediatr Radiol1987;17:68?70	3822585
3.Tam PKH, Chan FL, Saing H. Direct sagittal CTscan: a new diagnostic approach for surgical neo-nates. J Pediatr Surg1987;22:397?400	3585662
4.Higgins WE, Ramaswamy K, Swift RD, McLen-nan G, Hoffman EA. Virtual bronchoscopy forthree-dimensional pulmonary image assessment:state of the art and future needs. RadioGraphics1998;18:761?778	9599397
5.Ferretti GR, Vining DJ, Knoplioch J, CoulombM. Tracheobronchial tree: three-dimensional spi-ral CT with bronchoscopic perspective. J ComputAssist Tomogr1996;20:777?781	8797912
6.Summers RM, Shaw DJ, Shelhamer JH. CT virtualbronchoscopy of simulated endobronchial lesions:effect of scanning, reconstruction, and display set-tings and potential pitfalls. AJR1998;170:947?950	9530041
7.Konen E, Katz M, Rozenman J, Ben-Shlush A,Itzchak Y, Szeinberg A. Virtual bronchoscopy inchildren: early clinical experience. AJR1998171:1699?1702	9843316
2.Weissmann, G., J.E. Smolen, and H.M. Korchak. 1980. Re-lease of inflammatory mediators from stimulated neutrophils.N. Engl. J. Med. 303:27?34.	6246431
3.Samuelsson, B. 1982. From studies of biochemical mecha-nisms to novel biological mediators: prostaglandin endoper-oxides, thromboxanes and leukotrienes. In Les Prix Nobel:Nobel Prizes, Presentations, Biographies and Lectures. T.Frï¿½ngsmyr, editor. Almqvist & Wiksell, Stockholm. 153?174.	6315101
4.Yokomizo, T., T. Izumi, K. Chang, Y. Takuwa, and T.Shimizu. 1997. A G-protein-coupled receptor for leuko-triene B4 that mediates chemotaxis. Nature. 387:620?624.	9177352
5.Perez, H.D. 1994. Chemoattractant receptors. Curr. Opin.Hematol. 1:40?44.	9371258
7.Serhan, C.N., J.Z. Haeggstrom, and C.C. Leslie. 1996. Lipidmediator networks in cell signaling: update and impact of cy-tokines. FASEB J. 10:1147?1158.	8751717
8.Diamond, P., A. McGinty, D. Sugrue, H.R. Brady, and C.Godson. 1999. Regulation of leukocyte trafficking by li-poxins. Clin. Chem. Lab. Med. 37:293?297.	10353475
9.Node, K., Y. Huo, X. Ruan, B. Yang, M. Spiecker, K. Ley,D.C. Zeldin, and J.K. Liao. 1999. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.Science. 285:1276?1279.	10455056
10.Munger, K.A., A. Montero, M. Fukunaga, S. Uda, T. Yura,E. Imai, Y. Kaneda, J.M. Valdivielso, and K.F. Badr. 1999.Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis. Proc. Natl. Acad. Sci. USA. 96:13375?13380.	10557328
12.Marcus, A.J. 1995. Aspirin as prophylaxis against colorectal cancer. N. Eng. J. Med. 333:656?658.	7637730
13.Takano, T., S. Fiore, J.F. Maddox, H.R. Brady, N.A. Peta-sis, and C.N. Serhan. 1997. Aspirin-triggered 15-epi-lipoxinA4 (LXA4) and LXA4 stable analogs are potent inhibitors of acute inflammation: evidence for anti-inflammatory recep-tors. J. Exp. Med. 185:1693?1704.	9151906
14.Clish, C.B., J.A. O?Brien, K. Gronert, G.L. Stahl, N.A. Peta-sis, and C.N. Serhan. 1999. Local and systemic delivery of astable aspirin-triggered lipoxin prevents neutrophil recruit-ment in vivo. Proc. Natl. Acad. Sci. USA. 96:8247?8252.	10393980
15.Chiang, N., K. Gronert, C.B. Clish, J.A. O?Brien, M.W.Freeman, and C.N. Serhan. 1999. Leukotriene B4 receptortransgenic mice reveal novel protective roles for lipoxins andaspirin-triggered lipoxins in reperfusion. J. Clin. Invest. 104:309?316.	10430612
16.Hachicha, M., M. Pouliot, N.A. Petasis, and C.N. Serhan.1999. Lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4inhibit tumor necrosis factor a?initiated neutrophil responses and trafficking: regulators of a cytokine?chemokine axis. J.Exp. Med. 189:1923?1929.	10377187
17.Fiore, S., J.F. Maddox, H.D. Perez, and C.N. Serhan. 1994.Identification of a human cDNA encoding a functional highaffinity lipoxin A4 receptor. J. Exp. Med. 180:253?260.	8006586
18.Fiore, S., and C.N. Serhan. 1995. Lipoxin A4 receptor acti-vation is distinct from that of the formyl peptide receptor inmyeloid cells: inhibition of CD11/18 expression by lipoxinA4-lipoxin A4 receptor interaction. Biochemistry. 34:16678?16686.	8527441
19.Quehenberger, O., E.R. Prossnitz, S.L. Cavanagh, C.G. Coch-rane, and R.D. Ye. 1993. Multiple domains of the N-formylpeptide receptor are required for high-affinity ligand binding.Construction and analysis of chimeric N-formyl peptide re-1207Chiang et al.ceptors. J. Biol. Chem. 268:18167?18175.	8349692
20.Castano, A.R., S. Tangri, J.E. Miller, H.R. Holcombe,M.R. Jackson, W.D. Huse, M. Kronenberg, and P.A. Peter-son. 1995. Peptide binding and presentation by mouse CD1.Science. 269:223?226.	7542403
21.Beckman, E.M., S.A. Porcelli, C.T. Morita, S.M. Behar,S.T. Furlong, and M.B. Brenner. 1994. Recognition of alipid antigen by CD1-restricted ab1 T cells. Nature. 372:691?694.	7527500
22.Brezinski, D.A., and C.N. Serhan. 1991. Characterization oflipoxins by combined gas chromatography and electron-cap-ture negative ion chemical ionization mass spectrometry: for-mation of lipoxin A4 by stimulated human whole blood. Biol.Mass Spectrom. 20:45?52.	1883860
23.Falk, W., R.H. Goodwin, and E. Leonard. 1980. A 48-wellmicrochemotaxis assembly for rapid and accurate measure-ment of leukocyte migration. J. Immunol. Methods. 33:239?247.	6989919
24.Gronert, K., S.P. Colgan, and C.N. Serhan. 1998. Charac-terization of human neutrophil and endothelial cell ligand-operated extracellular acidification rate by microphysiometry:impact of reoxygenation. J. Pharmacol. Exp. Ther. 285:252?261.	9536019
25.Wang, C.R., A.R. Castano, P.A. Peterson, C. Slaughter,K.F. Lindahl, and J. Deisenhofer. 1995. Nonclassical bindingof formylated peptide in crystal structure of the MHC class Ibmolecule H2-M3. Cell. 82:655?664.	7664344
26.Shawar, S.M., R.R. Rich, and E.L. Becker. 1995. Peptidesfrom the amino-terminus of mouse mitochondrially encodedNADH dehydrogenase subunit 1 are potent chemoattracta-nts. Biochem. Biophys. Res. Commun. 211:812?818.	7598710
27.Serhan, C.N., J.F. Maddox, N.A. Petasis, I. Akritopoulou-Zanze, A. Papayianni, H.R. Brady, S.P. Colgan, and J.L.Madara. 1995. Design of lipoxin A4 stable analogs that blocktransmigration and adhesion of human neutrophils. Biochem-istry. 34:14609?14615.	7578068
28.Klein, C., J.I. Paul, K. Sauve, M.M. Schmidt, L. Arcangeli, J.Ransom, J. Trueheart, J.P. Manfredi, J.R. Broach, and A.J.Murphy. 1998. Identification of surrogate agonists for thehuman FPRL-1 receptor by autocrine selection in yeast. Nat.Biotechnol. 16:1334?1337.	9853614
29.Tessier, P.A., P.H. Naccache, I. Clark-Lewis, R.P. Gladue,K.S. Neote, and S.R. McColl. 1997. Chemokine networksin vivo: involvement of C-X-C and C-C chemokines inneutrophil extravasation in vivo in response to TNF-a. J.Immunology. 159:3595?3602.	9317159
30.Gabay, C., and I. Kushner. 1999. Acute-phase proteins andother systemic responses to inflammation. N. Engl. J. Med.340:448?454.	9971870
31.Su, S.B., W. Gong, J.L. Gao, W. Shen, P.M. Murphy, J.J.Oppenheim, and J.M. Wang. 1999. A seven-transmembrane,G protein?coupled receptor, FPRL1, mediates the chemo-tactic activity of serum amyloid A for human phagocyticcells. J. Exp. Med. 189:395?402.	9892621
32.Miettinen, H.M., J.M. Gripentrog, and A.J. Jesaitis. 1998.Chemotaxis of chinese hamster ovary cells expressing the hu-man neutrophil formyl peptide receptor: role of signal trans-duction molecules and a5b1 integrin. J. Cell Sci. 111:1921?1928.	9645940
33.Maddox, J.F., M. Hachicha, T. Takano, N.A. Petasis, V.V.Fokin, and C.N. Serhan. 1997. Lipoxin A4 stable analogs arepotent mimetics that stimulate human monocytes and THP-1cells via a G-protein-linked lipoxin A4 receptor. J. Biol.Chem. 272:6972?6978.	9054386
34.Villanueva, M.S., C.J. Becker, and E.G. Pamer. 1994. Infection with Listeria monocytogenes impairs sialic acid addition tohost cell glycoproteins. J. Exp. Med. 180:2137?2145.	7964488
35.Olofsson, S., B. Khanna, and E. Lycke. 1980. Altered kineticproperties of sialyl and galactosyl transferases associated withherpes simplex virus infection of GMK and BHK cells. J.Gen. Virol. 47:1?9.	6154121
36.Kim, J.W., and J.M. Cunningham. 1993. N-linked glycosylation of the receptor for murine ecotropic retroviruses is altered in virus-infected cells. J. Biol. Chem. 268:16316?16320.	8393858
37.Miettinen, H.M., J.S. Mills, J.M. Gripentrog, E.A. Dratz,B.L. Granger, and A.J. Jesaitis. 1997. The ligand binding siteof the formyl peptide receptor maps in the transmembraneregion. J. Immunol. 159:4045?4054.	9378994
38.Quehenberger, O., Z.K. Pan, E.R. Prossnitz, S.L. Cavanagh,C.G. Cochrane, and R.D. Ye. 1997. Identification of anN-formyl peptide receptor ligand binding domain by a gain-of-function approach. Biochem. Biophys. Res. Commun. 238:377?381.	9299516
39.Tai, H.H., C. Huang, and N. Chiang. 1997. Structure andfunction of prostanoid receptors as revealed by site-directedmutagenesis. In Eicosanoids and Other Bioactive Lipids inCancer, Inflammation and Radiation Injury. K.V. Honn, L.J.Marnett, R. Jones, and P.Y.-K. Wong, editors. PlenumPress, New York. 205?209.	9321954
40.Fiore, S., S.W. Ryeom, P.F. Weller, and C.N. Serhan. 1992.Lipoxin recognition sites. Specific binding of labeled lipoxinA4 with human neutrophils. J. Biol. Chem. 267:16168?16176.	1322894
41.Liang, J.S., and J.D. Sipe. 1995. Recombinant human serumamyloid A (apoSAAp) binds cholesterol and modulates cho-lesterol flux. J. Lipid Res. 36:37?46.	7706946
42.Linke, R.P., V. Bock, G. Valet, and G. Rothe. 1991. Inhibi-tion of the oxidative burst response of N-formyl peptide-stimulated neutrophils by serum amyloid-A protein. Biochem.Biophys. Res. Commun. 176:1100?1105.	2039494
43.Deng, X., H. Ueda, S.B. Su, W. Gong, N.M. Dunlop, J.-L.Gao, P.M. Murphy, and J.M. Wang. 1999. A synthetic pep-tide derived from human immunodeficiency virus type 1gp120 downregulates the expression and function ofchemokine receptors CCR5 and CXCR4 in monocytes byactivating the 7-transmembrane G-protein-coupled receptorFPRL1/LXA4R. Blood. 94:1165?1173.	10438703
44.Pettit, E.J., and F.S. Fay. 1998. Cytosolic free calcium andthe cytoskeleton in the control of leukocyte chemotaxis.Physiol. Rev. 28:949?960.	9790567
45.Serhan, C.N. 1994. Lipoxin biosynthesis and its impact in in-flammatory and vascular events. Biochim. Biophys. Acta. 1212:1?25.	8155718
46.Levy, B.D., V.V. Fokin, J.M. Clark, M.J.O. Wakelam, N.A.Petasis, and C.N. Serhan. 1999. Polyisoprenyl phosphate(PIPP) signaling regulates phospholipase D activity: a ?stop?signaling switch for aspirin-triggered lipoxin A4. FASEB J.13:903?911.	10224233
47.Schaldach, C.M., J. Riby, and L.F. Bjeldanes. 1999. LipoxinA4: a new class of ligand for the Ah receptor. Biochemistry. 38:7594?7600.	10360957
48.Fernandez-Salguero, P., T. Pineau, D.M. Hilbert, T.McPhail, S.S.T. Lee, S. Kimura, D.W. Nebert, S. Rudikoff,J.M. Ward, and F.J. Gonzalez. 1995. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-bindingAh receptor. Science. 268:722?726.	7732381
1.Janeway, C.A., Jr. 1992. The immune system evolved to dis-tinguish infectious nonself from non-infectious self. Immunol.Today. 13:11?16.	1739426
2.Takahashi, K., M.J. Donovan, R.A. Rogers, and R.A.B.Ezekowitz. 1998. Distribution of murine mannose receptorexpression from early embryogenesis through to adulthood.Cell Tissue Res. 292:311?323.	9560474
3.Linehan, S.A., L. Martï¿½nez-Pomares, P.D. Stahl, and S. Gor-don. 1999. Mannose receptor and its putative ligands in normal murine lymphoid and nonlymphoid organs: in situ expression of mannose receptor by selected macrophages,endothelial cell, perivascular microglia, and mesangial cells,but not dendritic cells. J. Exp. Med. 189:1961?1972.	10377192
4.Stahl, P.D., and R.A.B. Ezekowitz. 1998. The mannose re-ceptor is a pattern recognition receptor involved in host de-fense. Curr. Opin. Immunol. 10:50?55.	9523111
5.Sallusto, F., M.I. Cella, C. Danieli, and A. Lanzavecchia.1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:389?400.	7629501
6.Prigozy, T.I., P.A. Sieling, D. Clemens, P.L. Stewart, S.M.1114Structure of Mannose Receptor Cysteine-rich DomainBehar, S.A. Porcelli, M.B. Brenner, R.L. Modlin, and M.Kronenberg. 1997. The mannose receptor delivers lipoglycanantigens to endosomes for presentation to T cells by CD1bmolecules. Immunity. 6:187?197.	9047240
7.Ishizaki, J., K. Hanasaki, K. Higashino, J. Kishimo, N. Kiku-chi, O. Ohara, and H. Arita. 1994. Molecular cloning of pan-creatic group I phospholipase A2 receptor. J. Biol. Chem.269:12156?12162.	7509792
8.Lambeau, G., P. Ancian, J. Barhanin, and M. Lazdunski.1994. Cloning and expression of a membrane receptor forsecretory phospholipases A2. J. Biol. Chem. 269:1575?1578.	8294398
9.Ancian, P., G. Lambeau, M.-G. Madei, and M. Lazdunski.1995. The human 180 kDa receptor for secretory phospholipases A2. J. Biol. Chem. 270:8963?8970.	7721806
10.Jiang, W.P., W.J. Swiggard, C. Heufler, M. Peng, A. Mirza,R.M. Steinman, and M.C. Nussenzweig. 1995. The receptorDEC-205 expressed by dendritic cells and thymic epithelialcells is involved in antigen processing. Nature. 375:151?155.	7753172
11.Wu, K., J. Yuan, and L.A. Lasky. 1996. Characterization of anovel member of the macrophage mannose receptor type Clectin family. J. Biol. Chem. 271:21323?21330.	8702911
12.Taylor, M.E., K. Bezouska, and K. Drickamer. 1992. Contri-bution to ligand binding by multiple carbohydrate recogni-tion domains in the macrophage mannose receptor. J. Biol.Chem. 267:1719?1726.	1730714
13.Taylor, M.E., and K. Drickamer. 1993. Structural require-ments for high affinity binding of complex ligands by themannose receptor. J. Biol. Chem. 268:399?404.	8416946
14.Weis, W.I., M.E. Taylor, and K. Drickamer. 1998. TheC-type lectin superfamily in the immune system. Immunol.Rev. 163:19?34.	9700499
15.Mullin, N.P., P.G. Hitchen, and M.E. Taylor. 1997. Mecha-nism of Ca21 and monosaccharide binding to a C-type car-bohydrate-recognition domain of the macrophage mannosereceptor. J. Biol. Chem. 272:5668?5681.	9038177
16.Fiete, D., and J.U. Baenziger. 1997. Isolation of the SO4-4-GalNAcb1, 4GlcNAcb1, 2Mana-specific receptor fromrat liver. J. Biol. Chem. 272:14629?14637.	9169424
17.Fiete, D., M.C. Beranek, and J.U. Baenziger. 1997. Themacrophage endothelial cell mannose receptor cDNA encodes a protein that binds oligosaccharides terminating with SO4-4-GalNAcb1,4GlcNAcb or Man at independent sites.Proc. Natl. Acad. Sci. USA. 94:11256?11261.	9326596
18.Fiete, D.J., M.C. Beranek, and J.U. Baenziger. 1998. A cysteine-rich domain of the ?mannose? receptor mediates Gal-NAc-4-SO4 binding. Proc. Natl. Acad. Sci. USA. 95:2089?2093.	9482843
19.Leteux, C., W. Chai, R.W. Loveless, C.-T. Yuen, L. Uhlin-Hansen, Y. Combarnous, M. Jankovic, S.C. Maric, Z. Misu-lovin, M.C. Nussenzweig, and T. Feizi. 2000. The cysteine-rich domain of the macrophage mannose receptor is a multispecific lectin which recognizes chondroitin sulfates A and B and sulfated oligosaccharides of blood-group Lewisa and Lewisxtypes in addition to the sulfated N-glycans of luteinizing hormone. J. Exp. Med. 191:1117?1126.	10748230
20.Baenziger, J.U., S. Kumar, R.M. Brodbeck, P.L. Smith, andM.C. Beranek. 1992. Circulatory half-life but not interaction with the lutropin chorionic-gonadotropin receptor is modulated by sulfation of bovine lutropin oligosaccharides. Proc.Natl. Acad. Sci. USA. 89:334?338.	1729704
21.Smith, P.L., G.R. Bousfield, S. Kuman, D. Fiete, and J.U.Baenziger. 1993. Equine lutropin and chorionic gonadotro-pin bear oligosaccharides terminating with SO4-4-GalNAcand Sia-a-2,3Gal, respectively. J. Biol. Chem. 268:795?802.	8419356
22.Martï¿½nez-Pomares, L., M. Kosco-Vilbois, E. Darley, P. Tree,S. Herren, J.-Y. Bonnefoy, and S. Gordon. 1996. Fc chimeric protein containing the cysteine-rich domain of the murine mannose receptor binds to macrophages from splenic marginal zone and lymph node subcapsular sinus and to germinal centers. J. Exp. Med. 184:1927?1937.	8920880
23.Taylor, M.E., J.T. Conary, M.R. Lennartz, P.D. Stahl, andK. Drickmer. 1990. Primary structure of the mannose recep-tor contains multiple motifs resembling carbohydrate-recog-nition domains. J. Biol. Chem. 265:12156?12162.	2373685
26.Abrahams, J.P., and A.G.W. Leslie. 1996. Methods used inthe structure determination of bovine mitochondrial F1 ATP-ase. Acta Crystallogr. D. 52:30?42.	15299723
27.Kleywegt, G.J., and T.A. Jones. 1997. Template convolutionto enhance or detect structural features in macromolecularelectron density maps. Acta Crystallogr. D. 53:179?185.	15299952
28.Jones, T.A., and M. Kjeldgaard. 1997. Electron density mapinterpretation. Methods Enzymol. 277:173?208.	18488310
29.Brï¿½nger, A.T., P.D. Adams, G.M. Clore, P. Gros, R.W.Grosse-Kunstleve, J.-S. Jiang, J. Kuszewski, M. Nilges, N.S.Pannu, R.J. Read, et al. 1998. Crystallography and NMRsystem: a new software system for macromolecular structuredetermination. Acta Crystallogr. D. 54:905?921.	9757107
30.Brï¿½nger, A.T. 1992. Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature. 355:472?475.	18481394
34.Murzin, A.G., A.M. Lesk, and C. Chothia. 1992. Beta-trefoilfold patterns of structure and sequence in the Kunitz inhibi-tors, interleukins-1b and 1a and fibroblast growth factors. J.Mol. Biol. 223:531?543.	1738162
35.McLachlan, A.D. 1979. Three-fold structural pattern in thesoybean trypsin inhibitory (Kunitz). J. Mol. Biol. 133:557?563.	537058
36.Rutenber, E., and J.D. Robertus. 1991. Structure of ricinB-chain at 2.5 ï¿½ resolution. Proteins. 10:260?269.	1881882
37.Zhu, X., H. Komiya, A. Chirino, S. Faham, G.M. Fox, T.Arakawa, B.T. Hsu, and D.C. Rees. 1991. Three-dimensional structures of acidic and basic fibroblast growth factors.Science. 251:90?93.	1702556
38.Finzel, B.C., L.L. Clancy, D.R. Holland, S.W. Muchmore,K.D. Watenpaugh, and H.M. Einspahr. 1989. Crystal struc-ture of recombinant human interleukin-1b at 2.0 ï¿½ resolu-tion. J. Mol. Biol. 209:779?791.	2585509
39.Graves, B.J., M.H. Hatada, W.A. Hendrickson, J.K. Miller,V.S. Madison, and Y. Satow. 1990. Structure of interleukin-1a at 2.7 ï¿½ resolution. Biochemistry. 29:2679?2684.1115Liu et al.	2346741
40.Habazetti, J., D. Gondol, R. Wiltscheck, J. Otlewski, M.Schleicher, and T.A. Holak. 1992. Structure of hisactophilinis similar to interleukin-1b and fibroblast growth factor. Na-ture. 359:855?858.	1436061
41.Harris, N., L.L. Peters, E.M. Eicher, M. Rits, D. Raspberry,Q.G. Eichbaum, M. Super, and R.A. Ezekowitz. 1994. Theexon-intron structure and chromosomal localization of themouse macrophage mannose receptor gene Mrc1: identifica-tion of a ricin-like domain at the N-terminus of the receptor.Biochem. Biophys. Res. Commun. 198:682?692.	8297379
42.Weis, W.I., and K. Drickamer. 1996. Structural basis of lec-tin-carbohydrate recognition. Annu. Rev. Biochem. 65:441?473.	8811186
43.Pflugrath, J.W., and F.A. Quiocho. 1988. The 2 ï¿½ resolutionstructure of the sulfate-binding protein involved in activetransport in Salmonella typhimurium. J. Mol. Biol. 200:163?180.	3288756
44.Quiocho, F.A., J.S. Sack, and N.K. Vyas. 1987. Stabilizationof charges on isolated ionic groups sequestered in proteins bypolarized peptide units. Nature. 329:561?564.	3657977
45.DiGabriele, A.D., I. Lax, D.I. Chen, C.M. Svahn, M. Jaye, J.Schlessinger, and W.A. Hendrickson. 1998. Structure of aheparin-linked biologically active dimer of fibroblast growthfactor. Nature. 393:812?817.	9655399
46.Perez, S., N. Mouhous-Riou, N.E. Nifant?ev, Y.E. Tsvet-kov, B. Bachet, and A. Imberty. 1996. Crystal and molecularstructure of a histo-blood group antigen involved in cell ad-hesion: the Lewisx trisaccharide. Glycobiology. 6:537?542.	8877374
47.Ng, K.K.-S., and W.I. Weis. 1997. Structure of a selectin-like mutant of mannose binding protein complexed with sial-ylated and sulfated Lewisx oligosaccharides. Biochemistry. 36:979?988.	9033386
48.Kogelberg, H., T.A. Frenkiel, S.W. Homans, A. Lubineau,and T. Feizi. 1996. Conformational studies on the selectinand natural killer cell receptor ligands sulfo- and sialyl-lacto-N-fucopentaoses (SuLNFPII and SLNFPII) using NMRspectroscopy and molecular dynamics simulations. Compari-sons with the nonacidic parent molecule LNFPII. Biochemis-try. 35:1954?1964.	8639679
49.Simpson, D.Z., P.G. Hitchen, E.L. Elmhirst, and M.E. Tay-lor. 1999. Multiple interactions between pituitary hormones and the mannose receptor. Biochem. J. 343:403?411.	10510307
50.Martï¿½nez-Pomares, L., J.A. Mahoney, R. Kï¿½poszta, S.A.Linehan, P.D. Stahl, and S. Gordon. 1998. A functional solu-ble form of the murine mannose receptor is produced bymacrophages in vitro and is present in mouse serum. J. Biol.Chem. 273:23376?23380.	9722572
52.Kolatkar, A.R., and W.I. Weis. 1996. Structural basis of ga-lactose recognition by C-type animal lectins. J. Biol. Chem.271:6679?6685.	8636086
1. Bairey Merz C, Dwyer J, Nordstrom C, Walton K, Salerno J, Schneider R. Psychosocial stress andcardiovascular disease: Pathophysiological links. Behav Med 2002;27:141?146. [PubMed: 12165968]	12165968
2. Tennant CC. Life stress and hypertension. J Cardiovasc Risk 2001;8:51?56. [PubMed: 11234726]	11234726
3. Penninx BW, Beekman AT, Honig A, et al. Depression and cardiac mortality: Results from a community based longitudinal study. Arch Gen Psychiatry 2001;58:221?227. [PubMed: 11231827]	11231827
4. Tennant CC, Mclean L. Mood disturbances and coronary heart disease: Progress in the past decade.Med J Aust 2000;172:151?152. [PubMed: 10772583]	10772583
5. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999;99:2192?2217. [PubMed:10217662]	10217662
7. Linden W, Stossel C, Maurice J. Psychosocial interventions for patients with coronary artery disease.Arch Intern Med 1996;156:745?752. [PubMed: 8615707]	8615707
8. Nunes E, Frank K, Kornfeld D. Psychologic treatment for Type A behavior pattern and for coronaryartery disease: A meta-analysis of the literature. Psychosom Med 1987;49:159?173. [PubMed:3554294]	3554294
10. Frasure-Smith N, Lesperance F, Prince RH, et al. Randomized trial of home-based psychosocialnursing intervention for patients recovering from myocardial infarction. Lancet 1997;350:473?479.[PubMed: 9274583]	9274583
11. Jones DA, West RR. Psychological rehabilitation after myocardial infarction: Multicentre randomised controlled trial. BMJ 1996;313:1517?1521. [PubMed: 8978226]	8978226
12. Orme-Johnson DW, Walton KG. All approaches to preventing or reversing effects of stress are notthe same. American Journal of Health Promotion 1998;12:297?299. [PubMed: 10181138]	10181138
13. Murphy LR. Stress management in work settings: A critical review of the health effects. AmericanJournal of Health Promotion 1996;11:112?135. [PubMed: 10163598]	10163598
17. Nader T, Rothenberg S, Averbach R, Charles B, Fields J, Schneider R. Improvements in chronic diseases with a comprehensive natural medicine approach: A review and case studies. Behav Med2000;26:34?46. [PubMed: 10971882]	10971882
18. Walton K, Pugh N. Stress, steroids, and ?ojas?: Neuroendocrine mechanisms and current promise ofancient approaches to disease prevention. Indian J Physiol Pharmacol 1995;39:3?36. [PubMed:7705867]	7705867
22. Jevning R, Wallace RK, Biedebach M. The physiology of meditation: A review. A wakefulhypometabolic integrated response. Neurosci Biobehav Rev 1992;16:415?424. [PubMed: 1528528]	1528528
26. Julkunen J, Salonen R, Kaplan G, Chesney M, Salonen J. Hostility and the progression of carotidatherosclerosis. Psychosom Med 1994;56:519?525. [PubMed: 7871107]	7871107
27. Reed DM, LaCroix AZ, Karasek RA, Miller D, MacLean CA. Occupational strain and the incidenceof coronary heart disease. Am J Epidemiol 1989;129:495?502. [PubMed: 2916542]	2916542
28. Hlatky MA, Lam LC, Lee KL, et al. Job strain and the prevalence and outcome of coronary artery disease. Circulation 1995;92:327?333. [PubMed: 7634445]	7634445
29. Grundy SM, Pasternak R, Greenland P, Smith SJ, Fuster V. AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statementfor healthcare professionals from the American Heart Association and the American College ofCardiology. J Am Coll Cardiol 1999;34:1348?1359. [PubMed: 10520820]	10520820
30. Schneider RH, Staggers F, Alexander C, et al. A randomized controlled trial of stress reduction forhypertension in older African Americans. Hypertension 1995;26:820?827. [PubMed: 7591024]	7591024
31. Alexander C, Schneider R, Staggers F, et al. A trial of stress reduction for hypertension in olderAfrican Americans (Part II): Sex and risk factor subgroup analysis. Hypertension 1996;28:228?237.[PubMed: 8707387]	8707387
33. Wenneberg S, Schneider R, Walton K, et al. A controlled study of the effects of the TranscendentalMeditation program on cardiovascular reactivity and ambulatory blood pressure. Int J Neurosci1997;89:15?28. [PubMed: 9134445]	9134445
34. Barnes VA, Treiber FA, Davis H. Impact of Transcendental Meditation on cardiovascular functionat rest and during acute stress in adolescents with high normal blood pressure. J Psychosom Res2001;51:597?605. [PubMed: 11595248]	11595248
36. Schneider R, Nidich S, Salerno J, et al. Lower lipid peroxide levels in practitioners of theTranscendental Meditation program. Psychosom Med 1998;60:38?41. [PubMed: 9492237]	9492237
39. Collins R, Petro R, MacMahone S, et al. Blood pressure, stroke, and coronary heart disease, part 2,Short-term reductions in blood pressure: Overview of randomized drug trials in their epidemiologicalcontext. Lancet 1990;335:827?838. [PubMed: 1969567]	1969567
40. Collins P, Fox K. Pathophysiology of angina. Lancet 1990;335:94?96. [PubMed: 1967428]	1967428
41. Cooper MJ, Aygen MM. Transcendental Meditation in the management of hypercholesterolemia.Journal of Human Stress 1979;5:24?27. [PubMed: 392003]	392003
42. Salonen JT, Yla-Herttuala S, Yamamoto R, et al. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet 1992;339:883?887. [PubMed: 1348295]	1348295
44. Berliner J, Navab M, Fogelman A, et al. Atherosclerosis: Basic mechanisms. Oxidation, inflammationand genetics. Circulation 1995;91:2488?2496. [PubMed: 7729036]	7729036
45. Matthews KA, Woodall KL, Allen MT. Cardiovascular reactivity to stress predicts future bloodpressure status. Hypertension 1993;22:479?485. [PubMed: 8406652]	8406652
46. Kamarck TW, Jennings JR, Pogue-Geile M, Manuck SB. A multidimensional measurement modelfor cardiovascular reactivity: Stability and cross-validation in two adult samples. Health Psychol1994;13:471?478. [PubMed: 7889901]	7889901
47. Eppley K, Abrams AI, Shear J. Differential effects of relaxation techniques on trait anxiety: A meta-analysis. J Clin Psychol 1989;45:957?974. [PubMed: 2693491]	2693491
48. Gaylord C, Orme-Johnson D, Travis F. The effects of the Transcendental Meditation technique andprogressive muscle relaxation on EEG coherence, stress reactivity, and mental health in black adults.Intern J Neurosci 1989;46:77?86.	2670798
51. Jevning R, Wilson AF, Smith WR. Adrenocortical activity during meditation. Hormones and Behavior1978;10:54?60. [PubMed: 350747]	350747
53. Michaels RR, Huber MJ, McCann DS. Evaluation of Transcendental Meditation as a method ofreducing stress. Science 1976;192:1242?1244. [PubMed: 775639]	775639
54. Mills PJ, Schneider RH, Hill D, Walton KG, Wallace RK. Beta-adrenergic receptor sensitivity insubjects practicing transcendental meditation. J Psychosom Res 1990;34:29?33. [PubMed: 2156071]	2156071
58. MacLean C, Walton K, Wenneberg S, et al. Effects of the Transcendental Meditation program onadaptive mechanisms: Changes in hormone levels and responses to stress after 4 months of practice.Psychoneuroendocrinology 1997;22:277?295. [PubMed: 9226731]	9226731
59. Infante JR, Peran F, Martinez M, et al. ACTH and beta-endorphin in Transcendental Meditation.Physiol Behav 1998;64:311?315. [PubMed: 9748098]	9748098
61. Barnes VA, Treiber FA, Turner JR, Davis H, Strong WB. Acute effects of Transcendental Meditationon hemodynamic functioning in middle-aged adults. Psychosom Med 1999;61:525?531. [PubMed:10443761]	10443761
63. Castillo-Richmond A, Schneider R, Alexander C, et al. Effects of stress reduction on carotidatherosclerosis in hypertensive African Americans. Stroke 2000;31:568?573. [PubMed: 10700487]	10700487
64. Fields JZ, Walton KG, Schneider RH, et al. Effect of a multimodality natural medicine program oncarotid atherosclerosis in older subjects: A pilot trial of Maharishi Vedic Medicine. Am J Cardiol2002;89:952?958. [PubMed: 11950434]	11950434
65. Blankenhorn DH, Hodis HN. Arterial imaging and atherosclerosis reversal. George Lyman DuffMemorial Lecture. Arteriosclerosis & Thrombosis 1994;14:177?192. [PubMed: 8305407]	8305407
69. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass andgeometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med1991;114:345?352. [PubMed: 1825164]	1825164
71. Devereux RB, Okin PM, Roman MJ. Pre-clinical cardiovascular disease and surrogate end-points inhypertension: Does race influence target organ damage independent of blood pressure? Ethnicity andDisease 1998;8:138?148. [PubMed: 9681280]	9681280
72. Devereux RB, Roman MJ, Ganau A, de Simone G, Okin PM, Kligfield P. Cardiac and arterialhypertrophy and atherosclerosis in hypertension. Hypertension 1994;23:802?809. [PubMed:8206580]	8206580
2.Quinn MJ, Babb PJ, Jones J, Allen E. Effect of screening on incidence and mortality from cancer of the cervix: evaluation based on routinely collected statistics. BMJ1999; 318:904-908.	10102852
3.Parkin DM, Nguyen-Dinh X, Day N. The impact of screening onthe incidence of cervical cancer in England and Wales. Br JObstet Gynaecol1985; 92:150-157.	3970894
4.Sasieni PD, Cuzick J, Lynch-Farmery E, NCN Working Group. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. Br J Cancer1996; 73:1001-1005.	8611418
6.Cockburn J, Redman S, Mill D, Henry E. Public understanding ofmedical screening. J Med Screening1995; 2: 224-227.	8719153
10.Sawaya GF, Brown AD, Washington AE, Garber AM. Current approaches to cervical screening. N Engl J Med 2001; 34(21):1603-1607.	11372013
1.Balbin EG, Ironson GH, Solomon GF. (1999) Stress and cop-ing: the psychoneuroimmunology of HIV/AIDS. Baillieres BestPract. Res. Clin. Ednocrinol. Metab.13: 615?633.	10903818
2.Chrousos GP. (2000) Stress, chronic inflammation, and emo-tional and physical well-being: concurrent effects and chronicsequelae. J. Allergy Clin. Immunol.106:275?291.	11080744
3.Yang EV, Glaser R. (2000) Stress-induced immunomodula-tion: impact on immune defenses against infectious disease.Biomed. Pharmacother.54: 245?250.	10917461
4.Swain MG, Patchev V, Vergalla J, et al. (1993) Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis. J. Clin. Invest.91:1903?1908.	8387536
5.Malan FS, Horak IG, de Vos V, van Wyk JA. (1997) Wildlifeparasites: lessons for parasite control in livestock. Vet. Para-sitol.71:137?153.	9261975
6.Kraabel BJ, Miller MW. (1997) Effect of simulated stress onsusceptibility of bighorn sheep neutrophils to Pasteurellahaemolytica leukotoxin.J. Wildl. Dis. 33: 558?566.	9249702
7.McEwen BS, Seeman T. (1999) Protective and damaging effectsof mediators of stress. Elaborating and testing the concepts ofallostasis and allostatic load. Ann. N.Y. Acad. Sci. USA896:30?47.	10681886
8.Birmaher B, Rabin BS, Garcia MR, et al. (1994) Cellular im-munity in depressed, conduct disorder, and normal adoles-cents: role of adverse life events. J. Am. Acad. Child Adolesc.Psychiatry33: 671?678.	8056730
9.Strange KS, Kerr LR, Andrews HN, et al. (2000) Psychosocialstressors and mammary tumor growth: an animal model.Neurotoxicol. Teratol.22: 89?102.	10642118
10.Elenkov IJ, Chrousos GP. (1999) Stress, cytokine patternsand susceptibility to disease. Baillieres Best Pract. Res. Clin.Endocrinol. Metab.13: 583?595.	10903816
11.Kiecolt-Glaser JK, Glaser R. (1999) Psychoneuroimmunologyand cancer: fact or fiction? Eur. J. Cancer35: 1603?1607.	10673969
12.Bauer ME, Vedhara K, Perks P, et al. (2000) Chronic stress incaregivers of dementia patients is associated with reducedlymphocyte sensitivity to glucocorticoids. J. Neuroimmunol.103: 84?92.	10674993
13.Lacey K, Zaharia MD, Griffiths J, et al. (2000) A prospectivestudy of neuroendocrine and immune alterations associatedwith the stress of an oral academic examination among grad-uate students. Psychoneuroendocrinol.25: 339?356.	10725611
14.Cohen S, Miller GE, Rabin BS. (2001) Psychological stressand antibody response to immunization: a critical review ofthe human literature. Psychosom. Med.63: 7?18.	11211068
15.Cacioppo JT, Poehlmann KM, Kiecolt-Glaser JK, et al. (1998)Cellular immune responses to acute stress in female care-givers of dementia patients and matched controls. HealthPsychol. 17: 182?189.	9548709
16.Weicker H, Werle E. (1991) Interaction between hormonesand the immune system. Int. J. Sports Med.12: S30?S37.	1894395
17.Ashwell JD, Lu FW, Vacchio MS. (2000) Glucocorticoids in Tcell development and function. Ann. Rev. Immunol.18: 309?345.	10837061
18.Rook GA. (1999) Glucocorticoids and immune function. Bail-lieres Best Pract. Res. Clin. Endocrinol. Metab.13: 567?581.	10903815
19.Nosseri C, Coppola S, Ghibelli L. (1994) Possible involve-ment of Poly(ADP-Ribosyl) polymerase in triggering stress-induced apoptosis. Exp. Cell Res.212: 367?373.	8187831
20.Pieper AA, Verma A, Zhang J, Snyder S. (1999) Poly (ADP-ribose) polymerase, nitric oxide, and cell death. Trends Phar-macol. Sci.20: 171?181.766Molecular Medicine,Volume 7, Number 6, November, 2001	10322503
21.Eliasson MJL, Sampei K, Mandir AS, et al. (1997) Poly(ADP-ribose) polymerase gene Disruption renders mice re-sistant to cerebral ischemia. Nature Med.3: 1089?1095.	9334719
22.Mandir AS, Przedborski S, Jackson-Lewis V, et al. (1999) Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkin-sonism. Proc. Natl. Acad. Sci.USA 96: 5774?5779.	10318960
23.Pieper AA, Walles T, Wei G, et al. (2000) Myocardial postis-chemic injury is reduced by poly ADP ribose polymerase-1gene disruption. Mol. Med.6: 271?282.	10949908
24.Pieper AA, Brat DJ, Krug DK, et al. (1999) Poly (ADP-ribose)polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc. Natl. Acad. Sci.96: 3059?3064.	10077636
25.Cossette S, Frasure-Smith N, Lesperance F. (2001) Clinicalimplications of a reduction in psychological distress on car-diac prognosis in patients participating in a psychosocial in-tervention program. Psychosom. Med.63: 257?266.	11292273
26.Haines A, Cooper J, Meade TW. (2001) Psychological characteristics and fatal ischaemic heart disease. Heart85: 385?389.	11250959
27.Naliboff BD, Goldstein IB, Shapiro D, Frank HJ. (1988) Mental and physical stress as moderators of the postural response in insulin-dependent diabetic patients. Health. Psychol.7:499?514.	3215159
28.Wang ZQ, Stingl L, Morrison C, et al. (1997) PARP is important for genomic stability but dispensable in apoptosis. GenesDev.11: 2347?2358.	9308963
29.Dixon F, Jacot-Guillarmod H, McConahey PJ. (1966) Theantibody responses of rabbits and rats to hemocyanin.J.Immunol.97: 350?355.	5925706
30.Drazen DL, Kriegsfeld LJ, Schneider JE, Nelson RJ. (2000)Leptin, but not immune function, is linked to reproductiveresponsiveness. Am. J. Physiol.278: 1401?1407.	10848504
31.Tsutsui N, Kamiyama T. (1998) Suppression of in vitro IFN-gamma production by spleen cells of Plasmodium chabaudi-infected C57BL/10 mice exposed to dexamethasone at a lowdose. Int. J. Immunopharmacol.20: 141?152.	9730250
32.DeVries AC, Gerber JM, Richardson HN, et al. (1997) Stressaffects corticosteroid and immunoglobulin concentrationsin male house mice (Mus musculus) and prairie voles (Micro-tus ochrogaster). Comp. Biochem. Physiol. A Physiol.118:655?663.	9406441
33.Shu J, Stevenson JR, Zhou X. (1993) Modulation of cellularimmune responses by cold water swim stress in the rat. DevComp Immunol17: 357?371.	8375569
35.Nelson RJ. (1997) The use of genetic ?knockout? mice inbehavioral endocrinology research. Horm. Behav.31: 188?196.	9213133
36.Kickhoefer VA, Siva AC, Kedersha NL, et al. (1999) The 193-kD vault protein, VPARP is a novel poly (ADP-ribose) polymerase. J. Cell Biol. 146:917?928.	10477748
37.Ame JC, Rolli V, Schreiber V, et al. (1999) PARP-2, a novelmammalian DNA damage-dependent Poly (ADP-ribose)polymerase. J. Biol. Chem.274: 17860?17868.	10364231
1.Minden A, Lin A, McMahon M, et al. (1994) Differential ac-tivation of ERK and JNK mitogen-activated protein kinasesby Raf-1 and MEKK. Science266:1719?1723.	7992057
2.Lee JC, Laydon JT, McDonnell PC, et al. (1994) A protein ki-nase involved in the regulation of inflammatory cytokinebiosynthesis. Nature372:739?746.	7997261
3.Coso OA, Chiariello M, Yu JC, et al. (1995) The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of theJNK/SAPK signaling pathway. Cell81:1137?1146.	7600581
4.Liu MK, Herrera-Velit P, Brownsey RW, Reiner NE. (1994)CD14-dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytestreated with bacterial lipopolysaccharide. J. Immunol.153:2642?2652.	7521366
5.Gupta S, Barrett T, Whitmarsh AJ, et al. (1996) Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO. J.15:2760?2770.	8654373
6.Hambleton J, Weinstein SL, Lem L, DeFranco AL. (1996) Activation of c-Jun N-terminal kinase in bacterial lipopolysac-charide-stimulated macrophages. Proc. Natl. Acad. Sci. USA93:2774?2778.	8610116
7.van den Blink B, Juffermans NP, ten Hove T, et al. (2001) p38mitogen-activated protein kinase inhibition increases cy-tokine release by macrophages in vitro and during infectionin vivo. J. Immunol.166:582?587.	11123340
8.Beyaert R, Cuenda A, Vanden Berghe W, et al. (1996) Thep38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor.EMBO. J.15:1914?1923.	8617238
9.Scherle PA, Jones EA, Favata MF, et al. (1998) Inhibition ofMAP kinase kinase prevents cytokine and prostaglandin E2production in lipopolysaccharide-stimulated monocytes. J.Immunol.161:5681?5686.	9820549
11.Carter AB, Monick MM, Hunninghake GW. (1999) Both Erkand p38 kinases are necessary for cytokine gene transcription.Am. J. Respir. Cell. Mol. Biol.20:751?758.	10101008
12.Zhu W, Downey JS, Gu J, et al. (2000) Regulation of TNF ex-pression by multiple mitogen-activated protein kinase path-ways. J. Immunol.164:6349?6358.	10843689
13.van der Poll T, Calvano SE, Kumar A, et al. (1995) Endotoxininduces downregulation of tumor necrosis factor receptors oncirculating monocytes and granulocytes in humans. Blood86:2754?2759.	7670115
14.van der Poll T, Coyle SM, Barbosa K, et al. (1996) Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J. Clin.Invest.97:713?719.	8609227
15.Versteeg HH, Nijhuis E, van den Brink GR, et al. (2000) A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinaseB and cAMP-response?element-binding protein. Biochem. J.350 Pt 3:717?722.	10970784
16.Yokoi T, Ohmichi M, Tasaka K, et al. (2000) Activation of theluteinizing hormone beta promoter by gonadotropin-releasing hormone requires c-Jun NH2-terminal protein ki-nase. J. Biol. Chem. 275:21639?21647.760Molecular Medicine,Volume 7, Number 11, November 2001	10787426
17.Medvedev AE, Kopydlowski KM, Vogel SN. (2000) Inhibi-tion of lipopolysaccharide-induced signal transduction inendotoxin-tolerized mouse macrophages: dysregulation ofcytokine, chemokine, and toll-like receptor 2 and 4 geneexpression. J. Immunol. 164:5564?5574.	10820230
18.Mendez C, Kramer AA, Salhab KF, et al. (1999) Tolerance to shock: an exploration of mechanism. Ann Surg229:843?849;discussion 849?850.	10363898
19.Jin H, Yang R, Marsters S, et al. (1995) Protection against endotoxic shock by bactericidal/permeability increasing protein in rats. J. Clin. Invest.95:1947?1952.	7706502
20.De Cesaris P, Starace D, Riccioli A, et al. (1998) Tumor necro-sis factor-alpha induces interleukin-6 production and inte-grin ligand expression by distinct transduction pathways. J.Biol. Chem.273:7566?7571.	9516459
21.Chan ED, Winston BW, Uh ST, et al. (1999) Evaluation of therole of mitogen-activated protein kinases in the expression ofinducible nitric oxide synthase by IFN-gamma and TNF-alpha in mouse macrophages. J. Immunol.162:415?422.	9886415
22.Nick JA, Avdi NJ, Gerwins P, et al. (1996) Activation of a p38mitogen-activated protein kinase in human neutrophils bylipopolysaccharide. J. Immunol.156:4867?4875.	8648136
23.Hambleton J, Weinstein SL, Lem L, DeFranco AL. (1996) Activation of c-Jun N-terminal kinase in bacterial lipopolysac-charide stimulated macrophages. Proc. Natl. Acad. Sci. USA93:2774?2778.	8610116
24.Avdi NJ, Nick JA, Whitlock BB, et al. (2001) Tumor necrosisfactor-alpha activation of the c-Jun N-terminal kinase path-way in human neutrophils. Integrin involvement in a path-way leading from cytoplasmic tyrosine kinases apoptosis. J.Biol. Chem. 276:2189?2199.	11053415
1.Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Parks CG,Gilkeson GS: Hormonal, environmental, and infectious riskfactors for developing systemic lupus erythematosus.ArthritisRheum1998, 41:1714-1724.	9778212
2.Robson MG, Walport MJ: Pathogenesis of systemic lupus ery-thematosus.Clin Exp Allergy2001, 31:678-685.	11422126
3.Du Clos TW: C-reactive protein as a regulator of autoimmunity and inflammation. Arthritis Rheum2003, 48:1475-1477.	12794811
4.Nauta AJ, Daha MR, Kooten C, Roos A: Recognition and clear-ance of apoptotic cells: arole for complement and pentraxins.Trends Immunol2003, 24:148-154.	12615211
5.Nagata S, Suda T: Fas and Fas ligand: lprand gldmutations.Immunol Today1995, 16:39-43.	7533498
6.Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG,Moroy T: Features of systemic lupus erythematosus in DNase1-deficient mice.Nat Genet2000, 25:177-181.	10835632
7.Emlen W, Niebur J, Kadera R: Accelerated in vitroapoptosis oflymphocytes from patients with systemic lupus erythemato-sus.J Immunol1994, 152:3685-3692.	8144943
8.Botto M, Dell?Agnola C, Bygrave AE, Petry F, Loos M, PandolfiPP, Walport MJ: Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies.NatGenet1998, 19:56-59.	9590289
9.Shoshan Y, Shapira I, Toubi E, Frolkis I, Yaron M, Mevorach D:Accelerated Fas-mediated apoptosis of monocytes andmaturing macrophages from patients with systemic lupuserythematosus: relevance to in vitroimpairment of interactionwith iC3b-opsonized apoptotic cells.J Immunol2001, 167:5963-5969.	11698475
10.Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB,Kalden JR: Impaired phagocytosis of apoptotic cell material bymonocyte-derived macrophages from patients with systemiclupus erythematosus.Arthritis Rheum1998, 41:1241-1250.	9663482
11.Fishelson Z, Attali G, Mevorach D: Complement and apoptosis.Mol Immunol2001, 38:207-219.	11532282
12.Charles PJ: Defective waste disposal: does it induce autoanti-bodies in SLE?Ann Rheum Dis2003, 62:1-3.	12480659
13.Voll RE, Roth EA, Girkontaite I, Fehr H, Herrmann M, Lorenz HM,Kalden JR: Histone-specific Th0 and Th1 clones derived fromsystemic lupus erythematosus patients induce double-stranded DNA antibody production.Arthritis Rheum1997, 40:2162-2171.	9416853
14.Mohan C, Adams S, Stanik V, Datta SK: Nucleosome: a major immunogen for pathogenic autoantibody-inducing Tcells of lupus.J Exp Med1993, 177:1367-1381.	8478612
15.Spronk PE, Limburg PC, Kallenberg CGM: Serological markersof disease activity in systemic lupus erythematosus.Lupus1995, 4:86-94.	7795629
16.Gewurz H, Zhang XH, Lint TF: Structure and function of the pentraxins.Curr Opin Immunol1995, 7:54-64.	7772283
17.Nauta AJ, Bottazzi B, Mantovani A, Salvatori G, Kishore U,Schwaeble WJ, Gingras AR, Tzima S, Vivanco F, Egido J, TijsmaO, Hack EC, Daha MR, Roos A: Biochemical and functionalcharacterization of the interaction between pentraxin 3andC1q.Eur JImmunol2003, 33:465-473.	12645945
18.Thompson D, Pepys MB, Wood SP: The physiological structureof human C-reactive protein and its complex with phospho-choline.Structure Fold Des1999, 7:169-177.	10368284
19.Motie M, Brockmeier S, Potempa LA: Binding of model solubleimmune complexes to modified C-reactive protein.J Immunol1996, 156:4435-4441.	8666818
20.Mold C, Baca R, Du Clos TW: Serum amyloid Pcomponentand C-reactive protein opsonize apoptotic cells for phagocy-tosis through Fc?Rs.J Autoimmun2002, 19:147-154.	12419285
21.Du Clos TW: The interaction of C-reactive protein and serumamyloid Pcomponent with nuclear antigens.Mol Biol Rep1996, 23:253-260.	9112237
24.Kresl JJ, Potempa LA, Anderson BE: Conversion of nativeoligomeric to amodified monomeric form of human C-reac-tive protein.Int JBiochem Cell Biol1998, 30:1415-1426.	9924810
25.Sjï¿½wall C, Eriksson P, Almer S, Skogh T: Autoantibodies to C-reactive protein is acommon finding in SLE, but not inprimary Sjï¿½gren?s syndrome, rheumatoid arthritis or inflam-matory bowel disease.J Autoimmun2002, 19:155-160.	12419286
26.Bell SA, Faust H, Schmid A, Meurer M: Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases.Clin Exp Immunol1998, 113:327-332.	9737658
27.Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH,and the Committee on Prognosis Studies in SLE: Derivation of the SLEDAI.Arthritis Rheum1992, 35:630-640.	1599520
28.Sturfelt G, Roux-Lombard P, Wollheim FA, Dayer JM: Low levelsof interleukin-1 receptor antagonist coincide with kidneyinvolvement in systemic lupus erythematosus.Br JRheumatol1997, 36:1283-1289.	9448589
29.Potempa LA, Siegel JN, Fiedel BA, Potempa RT, Gewurz H:Expression, detection and assay of aneoantigen (Neo-CRP)associated with afree, human C-reactive protein subunit.MolImmunol1987, 24:531-541.	2443837
30.Mullis KB, Faloona FA: Specific synthesis of DNA in vitrovia apolymerase-catalyzed chain reaction.Methods Enzymol1987,155:335-350.	3431465
31.Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M,Bacon P, Bombardieri S, Hanly J, Hay E, Isenberg D, Jones J,Kalunian K, Maddison P, Nived O, Petri M, Richter M, Sanchez-Guerrero J, Snaith M, Sturfelt G, Symmons D, Zoma A: The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythemato-sus.Arthritis Rheum1996, 39:363-369.	8607884
32.Jonsson H, Sturfelt G, Mï¿½rtensson U, Truedsson L, Sjï¿½holm AG:Prospective analysis of C1 dissociation and complement acti-vation in patients with systemic lupus erythematosus.ClinExp Rheumatol1995, 13:573-580.	8575134
33.Amoura Z, Koutouzov S, Piette JC: The role of nucleosomes inlupus.Curr Opin Rheumatol2000, 12:369-373.	10990171
34.Vigushin DM, Pepys MB, Hawkins PN: Metabolic and scintigraphic studies of radioiodinated human C-reactive protein inhealth and disease.J Clin Invest1993, 91:1351-1357.	8473487
35.Sturfelt G, Sjï¿½holm AG: Complement components, comple-ment activation, and acute phase response in systemiclupus erythematosus.Int Archs Allergy Appl Immun1984, 75:75-83.	6086533
36.Stein MP, Mold C, Du Clos TW: C-reactive protein binding tomurine leukocytes requires Fc?Rs.J Immunol2000, 164:1514-1520.	10640769
37.Khreiss T, Jozsef L, Hossain S, Chan JS, Potempa LA, Filep JG:Loss of pentameric symmetry of C-reactive protein is associ-ated with delayed apoptosis of human neutrophils.J BiolChem2002, 277:40775-40781.	12198121
38.Samberg NL, Bray RA, Gewurz H, Landay AL, Potempa LA: Pref-erential expression of neo-CRP epitopes on the surface ofhuman peripheral blood lymphocytes.Cell Immunol1988,116:86-98.	2458846
39.Bray RA, Samberg NL, Gewurz H, Potempa LA, Landay AL: C-reactive protein antigenicity on the surface of human periph-eral blood lymphocytes. Characterization of lymphocytesreactive with anti-neo-CRP.J Immunol1988, 140:4271-4278.	2453575
40.Cocca BA, Cline AM, Radic MZ: Blebs and apoptotic bodiesare Bcell autoantigens.J Immunol2002, 169:159-166.	12077241
41.Perniok A, Wedekind F, Herrmann M, Specker C, Schneider M:High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus.Lupus1998, 7:113-118.	9541096
42.Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy AL,Bell AL: Increased apoptotic peripheral blood neutrophils insystemic lupus erythematosus: relation with disease activity,antibodies to double stranded DNA, and neutropenia.AnnRheum Dis1999, 58:309-314.	10225817
43.Pascual M, Schifferli JA: Another function of erythrocytes:transport of circulating immune complexes.Infusionther Trans-fusionsmed1995, 22:310-315.	8924746
44.Klint C, Gullstrand B, Sturfelt G, Truedsson L: Binding ofimmune complexes to erythrocyte CR1 (CD35): difference inrequirement of classical pathway components and indicationof alternative pathway-mediated binding in C2-deficiency.Scand JImmunol2000, 52:103-108.	10886790
45.Skogh T, Stendahl O: Complement-mediated delay in immune complex clearance from the blood owing to reduced deposition outside the reticuloendothelial system.Immunology1983,49:53-59.	6404812
1.Abrahams JJ. The role of diagnostic imaging in dentalimplantology. Radiol Clin North Am 1993;31:163-180.	8419972
2.Frederiksen NL. Diagnostic imaging in dental implantology. OralSurg Oral Med Oral Pathol Oral Radiol Endod 1995;80:540-554.	8556464
3.Dharmar S. Locating the mandibular canal in panoramic radio-graphs. Int J Oral Maxillofac Implants 1997;12:113-117.	9048463
4.Lindh C, Petersson A. Radiologic examination for location of themandibular canal: a comparison between panoramic radiographyand conventional tomography. Int J Oral Maxillofac Implants1989;4:249-253.	2639123
5.Lindh C, Petersson A, Klinge B. Visualisation of the mandibularcanal by different radiographic techniques. Clin Oral Impl Res1992;3:90-97.	15900674
6.Stella JP, Tharanon W. A precise radiographic method to deter-mine the location of the inferior alveolar canal in the posterioredentulous mandible: implications for dental implants. Part 2:clinical application. Int J Oral Maxillofac Implants 1990;5:23-29.	2391136
7.Lee S, Morgano SM. A diagnostic stent for endosseous implantsto improve conventional tomographic radiographs. J ProsthetDent 1994;71:482-485.	8006844
8.Silverstein LH, Melkonian RW, Kurtzman D, Garnick JJ, LefkoveMD. Linear tomography in conjunction with pantomography inthe assessment of dental implant recipient sites. J Oral Implantol1994;20:111-117.	7869413
9.Butterfield KJ, Dagenais M, Clokie C. Linear tomography?s clini-cal accuracy and validity for presurgical dental implant analysis.Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:203-209.	9269023
10.Gher ME, Richardson AC. The accuracy of dental radiographictechniques used for evaluation of implant fixture placement. Int JPeriodont Rest Dent 1995;15:268-283.	7558660
11.Mayfield-Donahoo TL, Stokely EM, Jeffcoat MK. Blur reductionof conventional film-based tomograms for pre-surgical evalua-tion of potential mandibular implant sites. J Periodontol1997;68:362-368.	9150041
12.Todd AD, Gher ME, Quintero G, Richardson C. Interpretation oflinear and computed tomograms in the assessment of implantrecipient sites. J Periodontol 1993;64:1243-1249.	8106953
13.Potter BJ, Shrout MK, Russell CM, Sharawy M. Implant siteassessment using panoramic cross-sectional tomographic imag-ing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod1997;84:436-442.	9347511
15.Kaeppler G. New radiographic programs for transverse conven-tional tomograms in the dentomaxillofacial region. QuintessenceInt 1999;30:541-549.	10635267
16.Wyatt CCL, Pharoah MJ. Imaging techniques and image interpre-tation for dental implant treatment. Int J Prosthodont1998;11:442-452.	9922736
18.Catic A, Celebic A, Valentic-Peruzovic M, Catovic A,Vjekoslav J, Muretic I. Evaluation of the precision of dimen-sional measurements of the mandible on panoramic radiographs.Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86:242-248.	9720102
19.Batenburg RHK, Stellingsma K, Raghoebar GM, Vissink A.Bone height measurements on panoramic radiographs: theeffect of shape and position of edentulous mandibles. OralSurg Oral Med Oral Pathol Oral Radiol Endod 1997;84:430-435.	9347510
20.Xie Q, Soikkonen K, Wolf J, Mattila K, Gong M, Ainamo A.Effect of head positioning in panoramic radiography on verticalmeasurements: an in vitro study. Dentomaxillofac Radiol1996;25:61-66.	9446974
1.Bystrï¿½m A, Sundqvist G. Bacteriologic evaluation of the efficacyof mechanical root canal instrumentation in endodontic therapy.Scand J Dent Res 1981;89:321-328.	6947391
2.Ohara PK, Torabinejad M, Kettering JD. Antibacterial effect ofvarious endodontic irrigants on selected anaerobic bacteria.Endod Dent Traumatol 1993;9:95-100.	8243347
4.Ayhan H, Sultan N, Cirak M, Ruhi MZ, Bodur H. Antimicrobialeffects of various endodontic irrigants on selected microorgan-isms. Int Endod J 1999;32:99-102.	10371903
5.Gomes BPFA, Ferraz CCR, Vianna ME, Berber VB, Teixeira FB,Souza-Filho FJ. In vitro antimicrobial activity of several concen-trations of sodium hypochlorite and chlorhexidine gluconate inthe elimination of Enterococcus faecalis. Int Endod J 2001;34:424-428.	11556507
6.Bystrï¿½m A, Sundqvist G. The antibacterial action of sodiumhypochlorite and EDTA in 60 cases of endodontic therapy. IntEndod J 1985;18:35-40.	3922900
7.Heling I, Chandler NP. Antimicrobial effect of irrigant combina-tions within dentinal tubules. Int Endod J 1998;31:8-14.	9823123
8.Jeansonne MJ, White RR. A comparison of 2% chlorhexidinegluconate and 5.25% sodium hypochlorite as antimicrobial endo-dontic irrigant. J Endod 1994;20:276-278.	7931023
9.Ringel AM, Patterson SS, Newton CW, Miller CH, Mulhern JM.In vivo evaluation of chlorhexidine gluconate solution and so-dium hypochlorite solution as root canal irrigants. J Endod1982;8:200-204.	6955420
10.Siqueira JF, Batista MD, Fraga RC, Uzeda M. Antimicrobialeffects of endodontic irrigants on black-pigmented Gram-nega-tive anaerobes and facultative bacteria. J Endod 1998;24:414-416.	9693585
11.Estrela C, Estrela CRA, Barbin EL, Spanï¿½ JC, Marchesan MA,Pï¿½cora JD. Mechanism of action of sodium hypochlorite. BrazilDent J 2002;2:113-117.	12238801
12.Spangberg L, Engstrom B, Langeland K. Biological effect ofdental materials: 3 toxicity and antimicrobial effects of endodon-tic antiseptics in vitro. Oral Surg Oral Med Oral Pathol1973;36:856-871.	4208832
13.Holland R, Soares IJ, Soares IM. Influence of irrigation andBraz Dent J 14(3) 2003192C.R.A. Estrela et al.intracanal dressing on the healing process of dog?s teeth withapical periodontitis. Endod Dent Traumatol 1992;8:223-229.	1302685
15.Estrela C, Ribeiro RG, Estrela CRA, Pï¿½cora JD, Sousa-Neto MD.Antimicrobiol effect of 2% sodium hypochlorite and 2%chlorhexidine tested by different methods. Braz Dent J 2003; 14:58-62.	12656467
16.Spanï¿½ JCE, Barbin EL, Santos TC, Guimarï¿½es LF, Pï¿½cora JD.Solvent action of sodium hypochlorite on bovine pulp andphysico-chemical properties of resulting liquid. Braz Dent J2001;12:154-157.	11696909
17.Emilson CG. Susceptibility of various microorganisms to chlor-hexidine. J Dent Res 1977;85:255-265.	266752
18.Emilson CG. Potential efficacy of chlorhexidine against mutansstreptococci and human dental caries. J Dent Res 1994;73:682-691.	8163738
19.Buck RA, Cai J, Eleaser PD, Staat RH, Hurst HE. Detoxificationof endotoxin by endodontic irrigants and calcium hydroxide. JEndod 2001;27:325-327.	11485249
20.Barbosa SV, Spangberg LSW, Almeida D. Low surface tension ofcalcium hydroxide solutions in an effective antiseptic. Int EndodJ 1994; 27:6-10.	7806414
1.Dehal P, Satou Y, Campbell RK, Chapman J, Degnan B, De Tomaso A,Davidson B, Di Gregorio A, Gelpke M, Goodstein DM, et al.: The draft genome of Ciona intestinalis: insights into chordate and vertebrate origins. Science 2002, 298:2157-2167.	12481130
2.Schmidtke J, Epplen JT, Engel W: Genome analysis of Amphioxusand speculation as to the origin of contrasting vertebrategenome organization patterns. Comp Biochem Physiol 1979,63:455-458.	318423
3.Simmen MW, Bird A: Sequence analysis of transposable ele-ments in the sea squirt, Ciona intestinalis. Mol Biol Evol 2000,17:1685-1694.	11070056
4.Charlesworth B, Sniegowski P, Stephan W: The evolutionarydynamics of repetitive DNA in eukaryotes. Nature 1994,371:215-220.	8078581
5.Finnegan DJ: Eukaryotic transposable elements and genomeevolution. Trends Genet 1989, 5:103-107.	2543105
6.Finnegan DJ: Transposable elements. Curr Opin Genet Dev 1992,2:861-867.	1335807
7.Xiong Y, Eickbush TH: Origin and evolution of retro elements based upon their reverse transcriptase sequences. EMBO J1990, 9:3353-3362.	1698615
8.Luan DD, Korman MH, Jakubczak JL, Eickbush TH: Reverse tran-scription of R2Bm RNA is primed by a nick at the chromo-somal target site: a mechanism for non-LTRretrotransposition. Cell 1993, 72:595-605.	7679954
9.Burch JB, Davis DL, Haas NB: Chicken repeat 1 elements contain a pol-like open reading frame and belong to the non-long terminal repeat class of retrotransposons. Proc Natl AcadSci USA 1993, 90:8199-8203.	8396264
10.Martï¿½n F, Olivares M, Lï¿½pez MC: Do non-long terminal repeatretrotransposons have nuclease activity? Trends Biochem Sci1996, 21:283-285.	8772379
11.Malik HS, Burke WD, Eickbush TH: The age and evolution of non-LTR retrotransposable elements. Mol Biol Evol 1999, 16:793-805.	10368957
12.Malik HS, Eickbush TH: NeSL-1, an ancient lineage of site-specific non-LTR retrotransposons from Caenorhabditis elegans.Genetics 2000, 154:193-203.	10628980
13.Volff JN, Korting C, Schartl M: Multiple lineages of the non-LTRretrotransposon Rex1 with varying success in invading fishgenomes. Mol Biol Evol 2000, 17:1673-1684.	11070055
14.Lovsin N, Gubensek F, Kordi D: Evolutionary dynamics in anovel L2 clade of non-LTR retrotransposons inDeuterostomia. Mol Biol Evol 2001, 18:2213-2224.	11719571
15.Aparicio S, Chapman J, Stupka E, Putnam N, Chia JM, Dehal P, Christ-offels A, Rash S, Hoon S, Smit A, et al.: Whole-genome shotgun assembly and analysis of the genome of Fugu rubripes. Science2002, 297:1301-1310.	12142439
16.Albalat R, Permanyer J, Caï¿½estro C, Martï¿½nez-Mir A, Gonzï¿½lez-Angulo O, Gonzï¿½lez-Duarte R: The first non-LTR retrotranspo-son characterised in the cephalochordate amphioxus,BfCR1, shows similarities to CR1-like elements. Cell Mol Life Sci2003, 60:803-809.	12785727
17.Tu Z, Isoe J, Guzova JA: Structural, genomic, and phylogeneticanalysis of Lian, a novel family of non-LTR retrotransposonsin the yellow fever mosquito, Aedes aegypti. Mol Biol Evol 1998,15:837-853.	9656485
18.Burke WD, Malik HS, Jones JP, Eickbush TH: The domain structureand retrotransposition mechanism of R2 elements are con-served throughout arthropods. Mol Biol Evol 1999, 16:502-511.	10331276
19.Caï¿½estro C, Albalat R, Gonzï¿½lez-Duarte R: Isolation and charac-terization of the first non-autonomous transposable elementin amphioxus, ATE-1. Gene, in press.	14585499
20.Yoder JA, Walsh CP, Bestor TH: Cytosine methylation and the ecology of intragenomic parasites. Trends Genet 1997, 13:335-340.	9260521
21.Simmen MW, Leitgeb S, Charlton J, Jones SJ, Harris BR, Clark VH,Bird A: Nonmethylated transposable elements and methyl-ated genes in a chordate genome. Science 1999, 283:1164-1167.	10024242
22.Chaboissier MC, Bucheton A, Finnegan DJ: Copy number control of a transposable element, the I factor, a LINE-like element in Drosophila. Proc Natl Acad Sci USA 1998, 95:11781-11785.	9751742
23.Jensen S, Gassama MP, Heidmann T: Taming of transposable elements by homology-dependent gene silencing. Nat Genet 1999,21:209-212.	9988275
24.Flavell RB: Inactivation of gene expression in plants as a consequence of specific sequence duplication. Proc Natl Acad SciUSA 1994, 91:3490-3496.	8170935
25.Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997,25:3389-3402.	9254694
27.Church GM, Gilbert W: Genomic sequencing. Proc Natl Acad SciUSA 1984, 81:1991-1995.	6326095
28.Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG: The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.Nucleic Acids Res 1997, 25:4876-4882.	9396791
29.Page RDM: TREEVIEW: An application to display phylogenetic trees on personal computers. Comput Appl Biosci 1996,12:357-358.	8902363
30.Berezikov E, Bucheton A, Busseau I: A search for reverse transcriptase-coding sequences reveals new non-LTR retrotransposons in the genome of Drosophila melanogaster. Genome Biol2000, 1:research0012.1-0012.15.	11178266
31.Holt RA, Subramanian GM, Halpern A, Sutton GG, Charlab R, Nusskern DR, Wincker P, Clark AG, Ribeiro JM, Wides R, et al.: The genome sequence of the malaria mosquito Anophelesgambiae. Science 2002, 298:129-149.	12364791
32.Fawcett DH, Lister CK, Kellett E, Finnegan DJ: Transposable ele-ments controlling I-R hybrid dysgenesis in D. melanogasterare similar to mammalian LINEs. Cell 1986, 47:1007-1015.	2430722
1.Wang Z, Moult J: SNPs, protein structure, and disease. HumMutat 2001, 17:263-270.	11295823
2.Sunyaev S, Ramensky V, Koch I, Lathe W 3rd, Kondrashov AS, BorkP: Prediction of deleterious human alleles. Hum Mol Genet 2001,10:591-597.	11230178
3.Ng PC, Henikoff S: Predicting deleterious amino acid substitutions. Genome Res 2001, 11:863-874.	11337480
4.Chasman D, Adams M: Predicting the functional consequencesof non-synonymous single nucleotide polymorphisms: struc-ture-based assessment of amino acid variation. J Mol Biol 2001,307:683-706.	11254390
5.Miller MP, Kumar S: Understanding human disease mutationsthrough the use of interspecific variation. Hum Mol Genet 2001,10:2319-2328.	11689479
6.Terp BN, Cooper DN, Christensen IT, Jorgensen FS, Bross P,Gregersen N, Krawczak M: Assessing the relative importance ofthe biophysical properties of amino acid substitutions associ-ated with human genetic disease. Hum Mutat 2002, 20:98-109.	12124990
8.Bairoch A, Apweiler R: The SWISS-PROT protein sequencedata bank and its new supplement TrEMBL. Nucleic Acids Res1996, 24:21-25.	8594581
9.Stephens JC, Schneider JA, Tanguay DA, Choi J, Acharya T, Stanley SE,Jiang R, Messer CJ, Chew A, Han JH, et al.: Haplotype variation andlinkage disequilibrium in 313 human genes. Science 2001,293:489-493.	11452081
11.Halushka MK, Fan JB, Bentley K, Hsie L, Shen N, Weder A, CooperR, Lipshutz R, Chakravarti A: Patterns of single-nucleotide poly-morphisms in candidate genes for blood-pressurehomeostasis. Nat Genet 1999, 22:239-247.	10391210
12.Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N,Lane CR, Lim EP, Kalyanaraman N, et al.: Characterization of sin-gle-nucleotide polymorphisms in coding regions of humangenes. Nat Genet 1999, 22:231-238.	10391209
13.Hess ST, Blake JD, Blake RD: Wide variations in neighbor-dependent substitution rates. J Mol Biol 1994, 236:1022-1033.	8120884
14.Sonnhammer EL, von Heijne G, Krogh A: A hidden Markov modelfor predicting transmembrane helices in protein sequences.Proc Int Conf Intell Syst Mol Biol 1998, 6:175-182.	9783223
15.Benner SA, Cohen MA, Gonnet GH: Amino acid substitutionduring functionally constrained divergent evolution of pro-tein sequences. Protein Eng 1994, 7:1323-1332.	7700864
16.Cooper DN, Youssoufian H: The CpG dinucleotide and humangenetic disease. Hum Genet 1988, 78:151-155.	3338800
17.Krawczak M, Ball EV, Cooper DN: Neighboring-nucleotide effects on the rates of germline single base-pair substitution in human genes. Am J Hum Genet 1998, 63:474-488.	9683596
18.Ng PC, Henikoff S: Accounting for human polymorphisms predicted to affect protein function. Genome Res 2002, 12:436-446.	11875032
19.Ramensky V, Bork P, Sunyaev S: Human non-synonymous SNPs:server and survey. Nucleic Acids Res 2002, 30:3894-3900.	12202775
20.Ferrer-Costa C, Orozco M, de la Cruz X: Characterization of dis-ease-associated single amino acid polymorphisms in termsof sequence and structure properties. J Mol Biol 2002, 315:771-786.	11812146
21.Bustamante CD, Townsend JP, Hartl DL: Solvent accessibility andpurifying selection within proteins of Escherichia coli and Sal-monella enterica. Mol Biol Evol 2000, 17:301-308.	10677853
22.Grantham R: Amino acid difference formula to help explainprotein evolution. Science 1974, 185:862-864.	4843792
23.Fay JC, Wyckoff GJ, Wu CI: Positive and negative selection on the human genome. Genetics 2001, 158:1227-1234.	11454770
24.Terwilliger JD, Haghighi F, Heikkalinna TS, Goring HH: A biasedassessment of the use of SNPs in human complex traits. CurrOpin Genet Dev 2002, 12:726-734.	12433588
25.Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN: Meta-analysis of genetic association studies supports a contribu-tion of common variants to susceptibility to commondisease. Nat Genet 2003, 33:177-182.	12524541
26.Olins PO, Bauer SC, Braford-Goldberg S, Sterbenz K, Polazzi JO,Caparon MH, Klein BK, Easton AM, Paik K, Klover JA, et al.: Satura-tion mutagenesis of human interleukin-3. J Biol Chem 1995,270:23754-23760.	7559548
27.Huang W, Petrosino J, Hirsch M, Shenkin PS, Palzkill T: Amino acidsequence determinants of beta-lactamase structure andactivity. J Mol Biol 1996, 258:688-703.	8637002
28.Pakula AA, Sauer RT: Genetic analysis of protein stability andfunction. Annu Rev Genet 1989, 23:289-310.	2694933
29.Matthews BW: Structural and genetic analysis of the foldingand function of T4 lysozyme. FASEB J 1996, 10:35-41.	8566545
30.Nachman MW, Crowell SL: Estimate of the mutation rate per nucleotide in humans. Genetics 2000, 156:297-304.	10978293
31.Eyre-Walker A, Keightley PD: High genomic deleterious mutation rates in hominids. Nature 1999, 397:344-347.	9950425
32.Henikoff S, Henikoff JG: Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci USA 1992, 89:10915-10919.	1438297
33.Templeton AR, Clark AG, Weiss KM, Nickerson DA, Boerwinkle E,Sing CF: Recombinational and mutational hotspots within the human lipoprotein lipase gene. Am J Hum Genet 2000, 66:69-83.	10631137
34.Zavolan M, Kepler TB: Statistical inference of sequence-dependent mutation rates. Curr Opin Genet Dev 2001, 11:612-615.	11682302
35.Rogozin I, Kondrashov F, Glazko G: Use of mutation spectraanalysis software. Hum Mutat 2001, 17:83-102.	11180592
36.Wootton JC, Federhen S: Analysis of compositionally biasedregions in sequence databases. Methods Enzymol 1996, 266:554-571.	8743706
37.Holm L, Sander C: Removing near-neighbour redundancy fromlarge protein sequence collections. Bioinformatics 1998, 14:423-429.	9682055
38.Higgins DG, Thomposon JD, Gibson TJ: Using CLUSTAL for mul-tiple sequence alignments. Methods Enzymol 1996, 266:383-402.	8743695
39.Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lip-man DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acid Res 1997,25:3389-3402.	9254694
40.Bernstein FC, Koetzle TF, Williams GJB, Meyer EF Jr, Brice MD,Rodgers JR, Kennard O, Shimanouchi T, Tasumi M: The ProteinData Bank: A computer based archival file for macromolecu-lar structures. J Mol Biol 1977, 112:535-542.	875032
3.Yunis NA, Stone VE. Cardiac Manifestationsof HIV/AIDS: Areviewof disease spectrum and clinical management. J Acq Imm Def SyndrHum Retrovirol1998; 18: 145?154.	9637579
4.Hakim JG, Matenga JA, Siziya. Myocardial dys function in human immuno deficiency virus infection: an echocardiographic study of 157patients in hospital in Zimbabwe. Heart1996; 76: 161?165.	8795481
5.Herskowitz A, Vlahov D, Willoughby S, et al.Prevalence and inci-dence of left ventricular dysfunction in patients with human immuno-deficiency infection. Am J Cardiol1993; 71: 955?958.	8465788
6.Kinney EL, Brafman D, Wright RJ. Echocardiographic findings inpatients with acquired immunodeficiency syndrome (AIDS) andAIDS-related complex (ARC). Cathet Cardiocvasc Diagnosis1989;16: 182?185.	2920391
7.Lassaigne D, Greder A, Hedoire F, Grollier G, Potier JC, Bazin C.Myocardial involvement in AIDS: Echographic study in 85 humanimmunodeficiency virus infected patients. Ann Med Interne Paris1991; 142: 205?208.	1854133
8.Barbaro G, Di Lorenzo G, Grisario B, Bacbarini G. Incidence of dilated cardiomyopathy and detection of HIVin myocardial cells of HIVpositive patients. N Engl J Med 1998; 16: 1039?1099.	9770555
9.Longo-Mbenza B, Seghers KV, Phuati M, Nkiabungu Bikangi F,Mubagwa K. Heart involvement in HIVinfection in African patients:Determinants of survival. Int J Cardiol 1998; 64: 63?73.	9579818
10.Kaul S, Fishbein MC, Siegel RJ. Cardiac manifestations of acquiredimmune deficiency syndrome. Am Heart J1991; 122: 535?544.	1858638
11.Anderson DW, Virmani R, Reilly JM, O?Leary T, Cunnion RE,Robinowits M, et al. Prevalent myocarditis at necropsy in the acquiredimmunodeficiency syndrome. J Am Coll Cardiol 1988; 11:792?799.	3351145
13.Cotton P. AIDS giving rise to cardiac problems. J Am Med Assoc1990;263: 2149.	2319673
14.Grody WW, Cheng L, Lewis W. Infection of the heart by the humanimmunodeficiency virus. Am J Cardiol1990; 66: 203?206.	2371952
15.Flomenbaum M, Soeiro Rm Udem SA, Kress Y, Factor SM.Proliferative membranopathy and human immunodeficiency virus inAIDS hearts. J AIDS1989; 2: 129?135.	2539451
16.Herskowitz A, Nieumann DA, Ansari AA. Concepts of auto immunity applied to idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1993;22: 1385?1388.	8227795
17.Patel RC, Frishman WH. Cardiac involvement in HIVinfection. MedClin North Am 1996; 80: 1493?1512.	8941233
18.Dworkin BM, Antonecchia PP, Smith F, et al. Reduced cardiac selenium content in AIDS. J Parenter Enteral Nutr 1989; 13: 644?647.	2614866
19.Cegielski JP, Lwakatare J, Dukes CS, et al. Tuberculous pericarditis in Tanzanian patients with and without HIV infection. Tuber Lung Dis1994; 75: 429?434.	7718831
20.Longo_Mbenza B, Tonduangu K, Seghers KV, Mubazwa D. HIV infection and pericardial disease invasion in Africa. Arch M CoeurVaiss 1997; 90: 1377?1384.	9539838
21.Flum DR, McGinn JTJr, Tyras DH. The role of the ?pericardial win-dow?in AIDS. Chest1995; 107: 1522?1525.	7781340
22.Herskowitz A, Willonguby SB, BaughmanKL, Schulman SP, BartlettJD. Cardiomyopathy associated with antiretroviral therapy in patientswith HIVinfection: a report of six cases. Ann Intern Med1992; 116:311?313.	1733387
23.Domanski MJ, Sloas MM, Follmann DA. Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus. J Pediatr1995; 127: 137?146.	7608800
24.Carr A, Samaras K, Burton S, Lan M, Freund J, Chrisholm DJ, CooperDA. Asyndrome of peripheral lipodystrophy hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS1998; 12: 51?58.	9619798
25.Gallet B, Pulik M, Genet P, Chedin P, Hictgen M. Vascular complications associated with the use of HIV protease inhibitors (letter). Lancet1998; 351: 1959.	9654285
27.Bozzette SA, Ake CF, Tam HK, et al. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 2003; 348: 702.	12594314
28.Duong M, Buisson M, Cottin Y, Piroth L, Lhuillier I, Grappin M, et al.Coronary heart disease associated with the use of human immunodefi-ciency virus (HIV)-1 protease inhibitors: Report of four cases andreview. Clin Cardiol 2001; 24: 690?694.	11594416
